Glycoproteins are proteins that carry N- and O-glycosidically-linked carbohydrate chains of complex structures and functions. N-glycan chains are assembled in the endoplasmic reticulum and the Golgi by a controlled sequence of glycosyltransferase and glycosidase processing reactions involving dolichol intermediates. The assembly of O-glycans occurs in the Golgi and does not involve dolichol. For most reactions, families of glycosyltransferases exist; the expression of the individual enzymes within a family is often subject to complex regulation. The biosynthesis of N- and O-glycan is controlled at the level of gene expression, mRNA, enzyme protein activity and localization, and through substrate and cofactor concentrations at the site of synthesis. This complex regulation results in many hundreds of structures, the range of which varies in different species, cell types, tissue types, states of development and differentiation. In diseased cells, the relative proportions of these structures are often characteristically different from normal, and may be useful for the assessment of the stage of the disease and for diagnosis. Knowledge of disease-specific glycoprotein structures and their functions may be used therapeutically, in immunotherapy, in blocking cell adhesion or interfering with other binding or biological processes. Recently, some of the mechanisms underlying glycoprotein alterations in disease have been elucidated. This opens the possibility of an active interference in the disease process. The functions of glycans in diseased cells will become more clear with the tools of molecular biology and transgenic animal models.

Keywords:
Glycoproteins, O-glycans, N-glycans, Glycosyltransferases, Biosynthesis
1.
Alam M, Miyoshi S, Tomochika K, Shinoda S (1997) Vibrio mimicus attaches to the intestinal mucosa by outer membrane hemagglutinins specific to polypeptide moieties of glycoproteins. Infect Immun 65: 3662–3665.
2.
Aldaheff J, Cimino G (1978) Cystic fibrosis liver sialyltransferase. Clin Genet 13: 207–212.
3.
Aldaheff JA, Holzinger RT (1982) Sialyltransferase, sialic acid and sialoglycoconjugates in metastatic tumors and human liver tissue. Int J Biochem 14: 119–126.
4.
Allen D, Connolly N, Biggart J (1988) Mucin profiles in ulcerative colitis with dysplasia and carcinoma. Histopathology 13: 413–424.
5.
Alton G, Kjaergaard S, Etchison JR, Skovby F, Freeze HH (1997) Oral ingestion of mannose elevates blood mannose levels: A first step toward a potential therapy for carbohydrate-deficient glycoprotein syndrome. Biochem Mol Med 60: 127–133.
6.
Amano J, Nishimura R, Mochizuki M, Kobata A (1988) Comparative study of the mucin-type sugar chains of human chorionic gonadotropin present in the urine of patients with trophoblastic diseases and healthy pregnant women. J Biol Chem 263: 1157–1165.
7.
Arango J, Pierce M (1988) Comparison of N-acetylglucosaminyltransferase V activities in Rous sarcoma-transformed baby hamster kidney (RS-BHK) and BHK cells. J Cell Biochem 37: 225–231.
8.
Asao T, Yazawa S, Nagamachi Y, Abbas SA, Matta KL (1989) Serum alpha (1-3)-L-fucosyltransferase, carcinoembryonic antigen, and sialyl Lewis X-i antigen levels in lung cancer. Cancer 64: 2541–2545.
9.
Augener W, Brittinger G, Schiphorst W, van den Eijnden D (1983) Activities and specificities of N-acetylglucosaminyltransferases in leukemic cells. Hämatol Bluttransfus 28: 135–138.
10.
Avila J, Rojas M, Towbin H (1988) Serological activity against galactosyl-α(1-3)galactose in sera from patients with several Kinetoplastida infections. J Clin Microbiol 26: 126–132.
11.
Baker M, Taub R, Whelton C, Hindenburg A (1984) Aberrant sialylation of granulocyte membranes in chronic myelogenous leukemia. Blood 63: 1194–1197.
12.
Baker M, Taub R, Kanani A, Brockhausen I, Hindenburg A (1985) Increased activity of a specific sialyltransferase in chronic myelogenous leukemia. Blood 66: 1068–1071.
13.
Baker M, Kanani A, Hindenberg A, Taub R (1986) Changes in the granulocyte membrane following chemotherapy for chronic myelogenous leukemia. Br J Hematol 62: 431–438.
14.
Baker M, Kanani A, Brockhausen I, Schachter H, Hindenberg A, Taub R (1987) Presence of cytidine 5′-monophospho-N-acetylneuraminic acid: Galβ1-3GalNAc-R α(2-3)-sialyltransferase in normal human leukocytes and increased activity of this enzyme in granulocytes from chronic myelogenous leukemia patients. Cancer Res 47: 2763–2766.
15.
Balagué C, Audié JP, Porchet N, Real FX (1995) In situ hybridization shows distinct patterns of mucin gene expression in normal, benign and malignant pancreas tissues. Gastroenterology 109: 953–964.
16.
Banerjee DK, Kousvelari EE, Baum BJ (1987) cAMP-mediated protein phosphorylation of microsomal membranes increases mannosylphosphodolichol synthase activity. Proc Natl Acad Sci USA 84: 6389–6393.
17.
Ben-Yoseph Y, DeFranco CL, Nadler HL (1981) The metabolism of sialic acid in cystic fibrosis. Pediatr Res 15: 839–842.
18.
Bennett EP, Hassan H, Clausen H (1996) cDNA cloning and expression of a novel human UDP-GalNAc: Polypeptide N-acetylgalactosaminyltransferase, GalNAc-T3. J Biol Chem 271: 17006–17012.
19.
Berger EG, Kozdrowski I (1978) Permanent mixed-field polyagglutinable erythrocytes lack galactosyltransferase activity. FEBS Lett 93: 105–108.
20.
Bergh LEM, Hooghwinkel GJM, van den Eijnden DH (1983) Biosynthesis of the O-glycosidically linked oligosaccharide chains of fetuin. Indications for an alpha-N-acetylgalactosaminide alpha 2-6 sialyltransferase with a narrow acceptor specificity in fetal calf liver. J Biol Chem 258: 7430–7436.
21.
Berndt M, Gregory C, Chong B, Zola H, Castaldi P (1983) Additional glycoprotein defects in Bernard-Soulier’s syndrome: Confirmation of genetic basis by parental analysis. Blood 62: 800–807.
22.
Bernstein H, Tucker S, Hunter E, Schutzbach J, Compans R (1994) Human immunodeficiency virus type 1 envelope glycoprotein is modified by O-linked oligosaccharides. Virology 68: 463–468.
23.
Beyer TA, Sadler JE, Rearick JI, Paulson JC, Hill RL (1981) Glycosyltransferases and their use in assessing oligosaccharide structure and structure-function relationships; in Meiser A (ed): Advances in Enzymology. New York, Wiley, pp 23–175.
24.
Bierhuizen MFA, Fukuda M (1992) Expression cloning of a cDNA encoding UDP-GlcNAc: Galbeta1-3-GalNAc-R (GlcNAc to GalNAc) beta1-6GlcNAc transferase by gene transfer into CHO cells expressing polyoma large tumor antigen. Proc Natl Acad Sci USA 89: 9326–9330.
25.
Bierhuizen M, Mattei MG, Fukuda M (1993) Expression of the developmental I antigen by a cloned human cDNA encoding a member of a beta-1,6-N-acetylglucosaminyltransferase gene family. Genes Dev 7: 468–478.
26.
Bierhuizen MFA, Maemura K, Kudo S, Fukuda M (1995) Genomic organization of core 2 and I branching β-1,6-N-acetylglucosaminyltransferases. Implication for evolution of the β-1,6-N-acetylglucosaminyltransferase gene family. Glycobiology 5: 417–425.
27.
Bithell T (1993) Disorders of hemostasis and coagulation; in Lee G, Bithell T, Foerster J, Athens J, Lukens J (eds): Wintrobe’s Clinical Hematology, ed 9. Philadelphia, Lea & Febiger, pp 1432–1433.
28.
Boland C, Lance P, Levin B, Riddell R, Kim Y (1984) Abnormal goblet cell glycoconjugates in rectal biopsies associated with an increased risk of neoplasia in patients with ulcerative colitis: Early results of a prospective study. Gut 25: 1364–1371.
29.
Bond A, Alavi A, Axford JS, Youinou P, Hay FC (1996) The relationship between exposed galactose and N-acetylglucosamine residues on IgG in rheumatoid arthritis (RA), juvenile chronic arthritis (JCA) and Sjögren’s syndrome (SS). Clin Exp Immunol 105: 99–103. Bresalier RS, Niv Y, Byrd JC, Duh Q-Y, Toribara N, Rockwell RW, Dahiya R, Kim YS (1991) Mucin production by human colonic carcinoma cells correlates with their metastatic potential in animal models of colon cancer metastasis. J Clin Invest 87: 1037–1045.
30.
Bresalier R, Ho S, Schoeppner H, Kim Y, Sleisenger M, Brodt P, Byrd J (1996) Enhanced sialylation of mucin-associated carbohydrate structures in human colon cancer metastasis. Gastroenterology 110: 1354–1367.
31.
Brockhausen I, Williams D, Matta KL (1983) Mucin synthesis. III. UDP-GlcNAc:Galβ1-3(GlcNAcβ1-6)GalNAc-R (GlcNAc to Gal) β3-N-acetylglucosaminyltransferase, an enzyme in porcine gastric mucosa involved in the elongation of mucin-type oligosaccharides. Can J Biochem Cell Biol 61: 1322–1333.
32.
Brockhausen I, Matta KL, Orr J, Schachter H (1985) Mucin synthesis. VI. UDP-GlcNAc: GalNAc-R β3-N-acetylglucosaminyltransferase and UDP-GlcNAc:GlcNAcβ1-3GalNAc-R (GlcNAc to GalNAc) β6-N-acetylglucosaminyltransferase from pig and rat colon mucosa. Biochemistry 24: 1866–1874.
33.
Brockhausen I, Hull E, Hindsgaul O, Schachter H, Shah R, Michnick S, Carver J (1989) Control of glycoprotein synthesis. Detection and characterization of a novel branching enzyme from hen oviduct, UDP-N-acetylglucosamine:GlcNAcβ1-6(GlcNAcβ1-2)Manα-R (GlcNAc to Man) β-4-N-acetylglucosaminyltransferase VI. J Biol Chem 264: 11211–11221.
34.
Brockhausen I, Möller G, Merz G, Adermann K, Paulsen H (1990) Control of glycoprotein synthesis: The peptide portion of synthetic O-glycopeptide substrates influences the activity of O-glycan core 1 uridine 5′-diphospho-galactose: N-acetylgalactosamineα-R β3-galactosyl-transferase. Biochemistry 29: 10206–10212. Brockhausen I, Romero P, Herscovics A (1991a) Glycosyltransferase changes upon differentiation of CaCo-2 human colonic adenocarcinoma cells. Cancer Res 5: 3136–3142.
35.
Brockhausen I, Kuhns W, Schachter H, Matta KL, Sutherland R, Baker MA (1991b) Biosynthesis of O-glycans in leukocytes from normal donors and from patients with chronic and acute myelogenous leukemia: Increase in O-glycan core 2 UDP-GlcNAc:Galβ3GalNAcα-R (GlcNAc to GalNAc) β6-N-acetylglucosaminyltransferase in leukemic cells. Cancer Res 51: 1257–1263. Brockhausen I, Möller G, Pollex-Krüger A, Rutz V, Paulsen H, Matta KL (1992a) Control of O-glycan synthesis: Specificity and inhibition of O-glycan core 1 UDP-galactose:N-acetylgalactosamine-α-R β3-galactosyltransferase from rat liver. Biochem Cell Biol 70: 99–108.
36.
Brockhausen I, Möller G, Yang J, Khan S, Matta K, Paulsen H, Grey A, Shah R, Schachter H (1992b) Control of glycoprotein synthesis. Characterization of (1-4)-N-acetyl-beta-D-glucosaminyltransferases acting on the alpha-D-(1-3)- and alpha-D-(1-6)linked arms of N-linked oligosaccharides. Carbohydr Res 236: 281–299.
37.
Brockhausen I (1993) Clinical aspects of glycoprotein biosynthesis. Crit Rev Clin Lab Sci 30: 65–151.
38.
Brockhausen I (1995) The biosynthesis of O-glycosylproteins; in Montreuil J, Vliegenthart JFG, Schachter H (eds): Glycoproteins 29a, New Comprehensive Biochemistry. New York, Elsevier, pp 201–259.
39.
Brockhausen I, Yang J, Burchell J, Whitehouse C, Taylor-Papadimitriou J (1995) Mechanism underlying aberrant glycosylation of the MUC1 mucin in breast cancer cells. Eur J Biochem 233: 607–617.
40.
Brockhausen I, Toki D, Brockhausen J, Peters S, Bielfeldt T, Kleen A, Paulsen H, Meldal M, Hagen F, Tabak L (1996) Specificity of O-glycosylation by bovine colostrum UDP-GalNAc: polypeptide α-N-acetylgalactosaminyltransferase using synthetic glycopeptide substrates. Glycoconj J 13: 849–856.
41.
Brockhausen I (1997) Glycosyltransferases involved in synthesis of Ser/Thr-GalNAc O-glycans; in Pinto M (ed): Comprehensive Natural Products Chemistry. Amsterdam, Elsevier Sciences.
42.
Brockhausen I, Schachter H (1997) Glycosyltransferases involved in N- and O-glycan biosynthesis; in Gabius HJ, Gabius S (eds): Glycosciences: Status and Perspectives. Weinheim, Chapman & Hall, pp 79–113.
43.
Brockhausen I, Kuhns W (1997a) Glycoproteins and Human Disease. New York, Chapman & Hall.
44.
Brockhausen I, Kuhns W (1997b) Role and metabolism of glycoconjugate sulfation. Trends Glycosci Glycotechnol 9: 379–398.
45.
Brockhausen I, Yang J, Dickinson N, Ogata S, Itzkowitz S (1998) Mechanism leading to the expression of the cancer-associated sialyl-Tn and Tn antigens in human cancer cells. Glycoconj J, in press.
46.
Brooks S, Leathem A (1991) Prediction of lymph node involvement in breast cancer by detection of altered glycosylation in the primary tumour. Lancet 338: 71–74.
47.
Buisine M, Janin A, Maunoury V, Audie J, Delescaut M, Copin M, Colombel J, Degand P, Aubert J, Porchet N (1996) Aberrant expression of a mucin gene (MUC5AC) in rectosigmoid villous adenomona. Gastroenterology 110: 84–91.
48.
Burke J, Pettitt J, Humphris D, Gleeson PA (1994) Medial-Golgi retention of N-acetylglucosaminyltransferase I – Contribution from all domains of the enzyme. J Biol Chem 269: 12049–12059.
49.
Cahan LD, Singh R, Paulson JC (1983) Sialyloligosaccharide receptors of binding variants of polyoma virus. Virology 130: 281–289.
50.
Carlsson SR, Sasaki H, Fukuda M (1986) Structural variations of O-linked oligosaccharides present in leukosialin isolated from erythroid, myeloid, and T-lymphoid cell lines. J Biol Chem 261: 12787–12795.
51.
Carter S, Slomiany A, Gwozdzinski K, Liau Y, Slomiany B (1988) Enzymatic sulfation of mucus glycoprotein in gastric mucosa. J Biol Chem 263: 11977–11984.
52.
Cartron J, Andrev J, Cartron J, Bird GWG, Salmon C, Gerbal A (1978) Demonstration of T-transferase deficiency in Tn-polyagglutinated blood samples. Eur J Biochem 92: 111–119.
53.
Chace K, Leahy D, Martin R, Carubelli R, Flux M, Sachdev G (1983) Respiratory mucous secretions in patients with cystic fibrosis: Relationship between levels of highly sulfated mucin component and severity of the disease. Clin Chim Acta 132: 142–155.
54.
Chandrasekaran EV, Davila M, Nixon DW, Goldfarb M, Mendicino J (1983) Isolation and structures of the oligosaccharide units of carcinoembryonic antigen. J Biol Chem 258: 7213–7222.
55.
Chandrasekaran EV, Jain RK, Matta KL (1992) Ovarian cancer α1,3-L-fucosyltransferase. J Biol Chem 267: 23806–23814.
56.
Chen M, Benjamin T (1997) Roles of N-glycans with α2,6 as well as α2,3 linked sialic acid in infection by polyoma virus. Virology 233: 440–442.
57.
Cheng P, Boat T, Cranfill K, Yankaskas J, Boucher R (1989) Increased sulfation of glycoconjugates by cultured nasal epithelial cells from patients with cystic fibrosis. J Clin Invest 84: 68–72.
58.
Chiba A, Matsumura K, Yamada H, Inazu T, Shimizu T, Kusunoki S, Kanazawa I, Kobata A, Endo T (1997) Structures of sialylated O-linked oligosaccharides of bovine peripheral nerve α-dystroglycan. The role of a novel O-mannosyl type oligosaccharide in the binding of α-dystroglycan. J Biol Chem 272: 2156–2162.
59.
Cho JW, Troy FA (1994) Polysialic acid engineering: Synthesis of polysialylated neoglycosphingolipids by using the polysialyltransferase from neuroinvasive Escherichia coli K1. Proc Natl Acad Sci USA 91: 11427–11431.
60.
Chui D, Oh-Eda M, Liao YF, Panneerselvam K, Lal A, Marek KW, Freeze HH, Moremen KW, Fukuda MN, Marth JD (1997) Alpha-mannosidase-II deficiency results in dyserythropoiesis and unveils an alternate pathway in oligosaccharide biosynthesis. Cell 90: 157–167.
61.
Clamp JR, Fraser G, Read AE (1981) Study of the carbohydrate content of mucus glycoproteins from normal and diseased colons. Clin Sci 61: 229–234.
62.
Clausen H, Bennett EP (1996) A family of UDP-GalNAc: Polypeptide N-acetylgalactosaminyl-transferases control the initiation of mucin-type O-linked glycosylation. Glycobiology 6: 635–646.
63.
Cohney S, McKenzie IF, Patton K, Prenzoska J, Ostenreid K, Fodor WL, Sandrin MS (1997) Down-regulation of Gal alpha(1,3)gal expression by alpha1,2-fucosyltransferase: Further characterization of alpha1,2-fucosyltransferase transgenic mice. Transplantation 64: 495–500.
64.
Cole LA (1987) The O-linked oligosaccharide structures are striking different on pregnancy and choriocarcinoma hCG. J Clin Endocrinol Metab 65: 811–813.
65.
Colley KJ, Lee EU, Adler B, Browne JK, Paulson JC (1989) Conversion of a Golgi apparatus sialyltransferase to a secretory protein by replacement of the NH2-terminal signal anchor with a signal peptide. J Biol Chem 264: 17619–17622.
66.
Colley KJ (1997) Localization of Golgi glycosyltransferases. Trends Glycosci Glycotechnol 9: 267–282.
67.
Colussi PA, Taron CH, Mack JC, Orlean P (1997) Human and Saccharomyces cerevisiae dolichol phosphate mannose synthase represents two classes of the enzyme, but both function in Schizosaccharomyces pombe. Proc Natl Acad Sci USA 94: 7873–7878.
68.
Cooper DKC, Oriol R (1997) Glycobiology in xenotransplantation research; in Gabius HJ, Gabius S (eds): Glycosciences Status and Perspectives. Weinheim, Chapman & Hall, pp 531–545.
69.
Corfield A, Wagner S, Clamp J, Kriaris MS, Hoskins LC (1992) Mucin degradation in the human colon. Production of sialidase, sialate O-acetylesterase, N-acetylneuraminate lyase, arylesterase and glycosulfatase activities by strains of fecal bacteria. Infect Immun 60: 3971–3978.
70.
Crookston JH, Crookston MC, Burnie KL, Francombe WH, Dacie JV, Davis JA, Lewis SM (1969) Hereditary erythroblastic mutinuclearity associated with a positive acidified-serum test: A type of congenital dyserythropoietic anemia. Br J Haematol 17: 11–26.
71.
Cummings RD (1992) Synthesis of asparagine-linked oligosaccharides: Pathways, genetics and metabolic regulation; in Allen HJ, Kisailus EC (eds): Glycoconjugates, Composition, Structure and Function. New York, Dekker, pp 333–360.
72.
Cummings RD, Nyame AK (1996) Glycobiology of schistosomiasis. FASEB J 10: 838–848.
73.
Dalgleish A, Beverley P, Clapham P, Crawford D, Greaves M, Weiss R (1984) The CD4 (T4) antigen is an essential component of the receptor for the AIDS virus. Nature 312: 763–767.
74.
Dall’Olio F, Malagolini N, Di Stefano G, Minni F, Marrano D, Serafini-Cessi F (1989) Increased CMP-NeuAc:Galβ1-4GlcNAc-R α2-6 sialyltransferase activity in human colorectal cancer tissues. Int J Cancer 44: 434–439.
75.
Dall’Olio F, Malagolini N, Serafini-Cessi F (1992) Enhanced CMP-NeuAc:Galbeta1,4GlcNAc-R alpha2,6 sialyltransferase activity of human colon cancer xenografts in athymic nude mice and of xenograft-derived cell lines. Int J Cancer 50: 325–330.
76.
Dall’Olio F, Malagolini N, Guerrini S, Lau J, Serafini-Cessi F (1996) Differentiation-dependent expression of human β-galacoside α2,6-sialyltransferase mRNA in colon carcinoma CaCo-2 cells. Glycoconj J 13: 115–121.
77.
Datta AK, Paulson JC (1995) The sialyltransferase ‘sialylmotif’ participates in binding the donor substrate CMP-NeuAc. J Biol Chem 270: 1497–1500.
78.
Dedera D, van der Heyden N, Ratner L (1990) Attenuation of HIV-1 infectivity by an inhibitor of oligosaccharide processing. AIDS Res Hum Retrovir 6: 785–793.
79.
Delannoy P, Kim I, Emery N, De Boloss C, Verbert A, Degand P, Huet G (1996) Benzyl-N-acetyl-α-D-galactosaminide inhibits the sialylation and the secretion of mucins by a mucin secreting HT-29 cell subpopulation. Glycoconj J 13: 717–726.
80.
de la Salle C, Lanza F, Cazenave JP (1995) Biochemical and molecular basis of Bernard-Soulier syndrome: A review. Nouv Rev Fr Hematol 37: 215–222.
81.
DeLuca GM, Donnell ME, Carrigan DJ, Blackall DP (1996) Plasmodium falciparum merozoite adhesion is mediated by sialic acid. Biochem Biophys Res Commun 225: 726–732.
82.
Demetriou M, Nabi I, Coppolino M, Dehar S, Dennis J (1995) Reduced contact inhibition and substratum adhesion in epithelial cells expressing GlcNAc-transferase V J Cell Biol 130: 383–392.
83.
Dennis J, Laferté S (1989) Oncodevelopmental expression of GlcNAc-β(1-6)Man-α(1-6) Man-β1-branched asparagine-linked oligosaccharides in murine tissues and human breast carcinomas. Cancer Res 49: 945–950.
84.
Dennis JW (1992) Changes in glycosylation associated with malignant transformation and tumor progression; in Fukuda M (ed): Cell Surface Carbohydrates and Cell Development. Boca Raton, CRC Press, pp 161–194.
85.
Denton G, Sekowski M, Price MR (1993) Induction of antibody responses to breast carcinoma associated mucins using synthetic peptide constructs as immunogens. Cancer Lett 70: 143–150.
86.
Dewar R, Vasudevachari M, Natarajan V, Salzman N (1989) Biosynthesis and processing of human immunodeficiency virus type 1 envelope glycoproteins: Effects of monensin on glycosylation and transport. J Virol 63: 2452–2456.
87.
Di Noia JM, Pollevick GD, Xavier MT, Previato JO, Mendoça-Previato L, Sánchez DO, Frasch ACC (1996) High diversity in mucin genes and mucin molecules in Trypanosoma cruzi. J Biol Chem 271: 32078–32083.
88.
Dorin J, Dickinson P, Alton E, Smith S, Geddes D, Stevenson B, Kimber W, Fleming S, Clarke A, Hooper M, Anderson L, Beddington R, Porteous D (1992) Cystic fibrosis in the mouse by targeted insertional mutagenesis. Nature 359: 211–215.
89.
Dosanjh A, Lencer W, Brown D, Ausiello D, Stow J (1994) Heterologous expression of delta F508 CFTR results in decreased sialylation of membrane glycoconjugates. Am J Physiol 266: C360–C366.
90.
Egea G, Francí C, Gambús G, Lesuffleur T, Zweibaum A, Real FX (1993) Cis-Golgi resident proteins and O-glycans are abnormally compartmentalized in the RER of colon cancer cells. J Cell Sci 105: 819–830.
91.
Estabrook M, Christopher N, Griffiss J, Baker C, Mandrell R (1992) Sialylation and neutrophil killing of group C Neisseria meningitidis. J Infect Dis 166: 1079–1088.
92.
Etzioni A, Frydman M, Pollack S, Avidor I, Phillips ML, Paulson JC, Gershoni-Baruch R (1992) Brief report: Recurrent severe infections caused by a novel leukocyte adhesion deficiency. N Engl J Med 327: 1789–1792.
93.
Favero J (1994) Lectins in AIDS research. Glycobiology 4: 387–396.
94.
Fernandes B, Sagman U, Auger M, Demetrio M, Dennis JW (1991) β1-6-branched oligosaccharides as a marker of tumor progression in human breast and colon neoplasia. Cancer Res 51: 718–723.
95.
Field MC, Wainwright LJ (1995) Molecular cloning of eukaryotic glycoprotein and glycolipid glycosyltransferases: A survey. Glycobiology 5: 463–472.
96.
Finn OJ, Jerome KR, Henderson RA, Pecher G, Domenech N, Magarian-Blander J, Barratt-Boyes SM (1995) MUC-1 epithelial tumor mucin-based immunity and cancer vaccines. Immunol Rev 145: 61–89.
97.
Forsee WT, Palmer CF, Schutzbach JS (1989) Purification and characterization of an α-1,2-mannosidase involved in processing asparagine-linked oligosaccharides. J Biol Chem 264: 3869–3876.
98.
Freed EO, Martin MA (1995) The role of human immunodeficiency virus type 1 envelope glycoproteins in virus infection. J Biol Chem 270: 23883–23886.
99.
Fukuda M, Bothner B, Ramsamoo P, Dell A, Tiller P, Varki A, Klock J (1985) Structures of sialylated fucosyl polylactosaminoglycans isolated from chronic myelogenous leukemia cells. J Biol Chem 260: 12957–12967.
100.
Fukuda M, Carlsson S, Klock J, Dell A (1986) Structures of O-linked oligosaccharides isolated from normal granulocytes, chronic myelogenous leukemia cells, and acute myelogenous leukemia cells. J Biol Chem 261: 12796–12806.
101.
Fukuda MN, Dell A, Scartezzini P (1987) Primary defect of congenital dyserythropoietic anemia type II: Failure in glycosylation of erythrocyte lactosaminoglycan proteins caused by lowered N-acetylglucosaminyltransferase II. J Biol Chem 262: 7195–7206.
102.
Fukuda MN (1990) HEMPAS disease: Genetic defect of glycosylation. Glycobiology 1: 9–15. Fukuda MN, Masri KA, Dell A, Luzzatto L, Moremen KW (1990) Incomplete synthesis of N-glycans in congenital dyserythropoietic anemia type II caused by a defect in the gene encoding α-mannosidase II. Proc Natl Acad Sci USA 87: 7443–7447.
103.
Fukuda M (1993) Congenital dyserythropoietic anaemia type II (HEMPAS) and its molecular basis. Baillières Clin Haematol 6: 493–511.
104.
Fukushi Y, Orikasa S, Shepard T, Hakomori S (1986) Changes of Lex and dimeric Lex haptens and their sialylated antigens during development of human kidney and kidney tumors. J Urol 126: 1048–1056.
105.
Furukawa K, Kobata A (1991) IgG galactosylation – Its biological significance and pathology. Mol Immunol 28: 1333–1340.
106.
Galili U, Macher B, Buehler J, Shohet S (1985) Human natural anti-α-galactosyl IgG. II. The specific recognition of α(1-3) linked galactose residues. J Exp Med 162: 573.
107.
Galili U, Shohet SB, Kobrin E, Stults CLM, Macher BA (1988) Man, apes and old world monkeys differ from other mammals in the expression of α-galactosyl epitopes on nucleated cells. J Biol Chem 263: 17755–17762.
108.
Garber N, Guempel U, Belz A, Gilboa-Garber N, Doyle RJ (1992) On the specificity of the D-galactose-binding lectin (PA-1) of Pseudomonas aeruginosa and its strong binding to hydrophobic derivatives of D-galactose and thiogalactose. Biochim Biophys Acta 1116: 331–333.
109.
Gentzsch M, Tanner W (1996) The PMT gene family: Protein O-glycosylation in Saccharomyces cerevisiae is vital. EMBO J 15: 5752–5759.
110.
Gerold P, Schuppert-Dieckmann A, Schwarz RT (1994) Glycosyl-phosphatidyl-inositols synthesized by asexual erythrocytic stages of the malaria parasite Plasmodium falciparum. Candidates for plasmodial glycosyl-phosphatidylinositol membrane anchor precursors and pathogenic factors. J Biol Chem 269: 2597–2606. Gersten KM, Natsuka S, Trinchera M, Petryniak B, Kelly RJ, Hiraiwa N, Jenkins NA, Gilbert DJ, Copeland NG, Lowe JB (1995) Molecular cloning, expression, chromosomal assignment, and tissue-specific expression of a murine α-(1,3)-fucosyltransferase locus corresponding to the human ELAM-1 ligand fucosyl transferase. J Biol Chem 270: 25047–25056.
111.
Geyer H, Holschback C, Hunsmann G, Schneider J (1988) Carbohydrates of human immunodeficiency virus: Structures linked to the envelope glycoprotein 120. J Biol Chem 263: 11760–11767.
112.
Gillespie W, Paulson J, Kelm S, Pang M, Baum L (1993) Regulation of α2,3-sialyltransferase expression correlates with conversion of peanut agglutinin (PNA)+ to PNA– phenotype in developing thymocytes. J Biol Chem 268: 3801–3804.
113.
Girling A, Bartkova J, Burchell J, Gendler S, Gillett C, Taylor-Papadimitriou J (1989) A core protein epitope of the polymorphic epithelial mucin detected by the monoclonal antibody SM-3 is selectively exposed in a range of primary carcinomas. Int J Cancer 43: 1072–1076.
114.
Gleeson PA, Teasdale RD, Burke J (1994) Targeting of proteins to the Golgi apparatus. Glycoconj J 11: 381–394.
115.
Gold P, Green M (1983) Partial purification and properties of a murine plasmacytoma glucosyltransferase. J Biol Chem 258: 12967–12975. Goso Y, Hotta K (1993) Characterization of a rat corpus sulfotransferase for the 6-0-sulfation of beta-D-N-acetylglucosamine residues on oligosaccharides. Glycoconj J 10: 226.
116.
Goupille C, Hallouin F, Meflah K, Le Pendu J (1997) Increase of rat colon carcinoma cells tumorigenicity by α(1-2) fucosyltransferase gene transfection. Glycoconj J 7: 221–229.
117.
Graham RA, Burchell JM, Taylor-Papadimitriou J (1996) The polymorphic epithelial mucin: Potential as an immunogen for a cancer vaccine. Cancer Immunol Immunother 42: 71–80.
118.
Granovsky M, Bielfeldt T, Peters S, Paulsen H, Meldal M, Brockhausen J, Brockhausen I (1994) O-glycan core 1 UDP-Gal:GalNAc β3-galactosyltransferase is controlled by the amino acid sequence and glycosylation of glycopeptide substrates. Eur J Biochem 221: 1039–1046.
119.
Green P, Tamatani T, Watanabe T, Miyasaki M, Hasegawa A, Kiso M, Yuen C, Stoll M, Feizi T (1992) High affinity binding of the leukocyte adhesion molecule, L-selectin, to sulfated Lewis oligosaccharides and the predominance of sulfate in this interaction demonstrated by binding studies with a series of lipid-linked oligosaccharides. Biochem Biophys Res Commun 188: 244–251.
120.
Gröttum KA, Solum NO (1969) Congenital thrombocytopenia with giant platelets: A defect in the platelet membrane. Br J Haematol 16: 277–289.
121.
Gu J, Kondo A, Okamoto N, Wada Y (1994) Oligosaccharide structures of immunoglobulin G from two patients with carbohydrate-deficient glycoprotein syndrome. Gycosyl Dis 1: 247–252.
122.
Haataja S, Tikkanen K, Liukkonen J, François-Gérard C, Finne J (1993) Characterization of a novel bacterial adhesion specificity of Streptococcus suis recognizing blood group P receptor oligosaccharides. J Biol Chem 268: 4311–4317.
123.
Hagen FK, Gregoire CA, Tabak LA (1995) Cloning and sequence homology of a rat UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase. Glycoconj J 12: 901–909.
124.
Hagen FK, Hagen KGT, Beres TM, Balys MM, VanWuyckhuyse BC, Tabak LA (1997) cDNA cloning and expression of a novel UDP-N-acetyl-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase. J Biol Chem 272: 13843–13848.
125.
Hajjar K, Reynolds C (1994) α-Fucose mediated binding and degradation of tissue type plasminogen activator by HepG2 cells. J Clin Invest 93: 703–710.
126.
Hakomori SI (1989) Aberrant glycosylation in tumors and tumor-associated carbohydrate antigens. Adv Cancer Res 52: 257–332.
127.
Hammond C, Braakman I, Helenius A (1994) Role of an N-linked olgosaccharide recognition, glucose trimming, and calnexin in glycoprotein folding and quality control. Proc Natl Acad Sci USA 91: 913–917.
128.
Hanisch FG, Hanski C, Hasegawa A (1992) Sialyl Lewis(x) antigen as defined by monoclonal antibody AM-3 is a marker of dysplasia in the colonic adenoma-carcinoma sequence. Cancer Res 52: 3138–3144.
129.
Hansen J, Clausen H, Nielsen C, Teglbjaerg L, Hansen L, Nielsen CM, Dabelsteen E, Mathiesen L, Hakomori S, Nielsen J (1990) Inhibition of human immunodeficiency virus (HIV) infection in vitro by anticarbohydrate monoclonal antibodies: Peripheral glycosylation of HIV envelope glycoprotein gp120 may be a target for virus neutralization. J Virol 64: 2833–2840.
130.
Hansen J (1992) Carbohydrates of human immunodeficiency virus. APMIS 100(suppl 27): 96–108.
131.
Hanski C, Klussmann E, Wang J, Böhm C, Ogorek D, Hanski ML, Krüger-Krasagakes S, Eberle J, Schmitt-Gräff A, Riecken EO (1996) Fucosyltransferase III and sialyl-Le(x) expression correlate in cultured colon carcinoma cells but not in colon carcinoma tissue. Glycoconj J 13: 727–733.
132.
Harduin-Lepers A, Shaper JH, Shaper NL (1993) Characterization of two cis-regulatory regions in the murine β1,4-galactosyltransferase gene: Evidence for a negative regulatory element that controls initiation at the proximal site. J Biol Chem 268: 14348–14359.
133.
Harduin-Lepers A, Recchi M-A, Delannoy P (1995) 1994, the year of sialyltransferases. Glycobiology 5: 741–758.
134.
Harris RJ, Spellman MW (1993) O-linked fucose and other posttranslational modifications unique to EGF modules. Glycobiology 3: 219–224.
135.
Hart GW, Kelly WG, Blomberg MA, Roquemore EP, Dong LYD, Kreppel L, Chou TY, Snow D, Greis K (1994) Glycosylation of nuclear and cytoplasmic proteins is as abundant and as dynamic as phosphorylation; in Glyco and Cell Biology, Mosbach Symposium 44. Heidelberg, Springer, pp 92–103.
136.
Hathaway HJ, Shur BD (1996) Mammary gland morphogenesis is inhibited in transgenic mice that overexpress cell surface β1,4-galactosyltransferase. Development 122: 2859–2872.
137.
Hayes BK, Hart GW (1994) Novel forms of protein glycosylation. Curr Opin Struct Biol 4: 692–696.
138.
Heffernan M, Lotan R, Amos B, Palcic M, Takano R, Dennis JW (1993) Branching beta 1-6N-acetylglucosaminyltransferase and polylactosamine expression in mouse F9 teratocarcinoma cells and differentiated counterparts. J Biol Chem 268: 1242–1251.
139.
Hemmerich S, Rosen SD (1994) 6′-Sulfated sialyl Lewis x is a major capping group of GlyCAM-1. Biochemistry 33: 4830–4835.
140.
Hemmerich S, Leffler H, Rosen S (1995) Structure of the O-glycans in GlyCAM-1, an endothelial-derived ligand for L-selectin. J Biol Chem 270: 12035–12047.
141.
Hennet T, Hagen FK, Tabak LA, Marth JD (1995) T-cell-specific deletion of a polypeptide N-acetylgalactosaminyltransferase gene by site-directed recombination. Proc Natl Acad Sci USA 92: 12070–12074.
142.
Herrler G, Rott R, Klenk HD, Müller HP, Shukla AK, Schauer R (1985) The receptor-destroying enzyme of influenza C virus is neuraminate-O-acetylesterase. EMBO J 4: 1503–1506.
143.
Herrler G, Gross HJ, Imhoff A, Brossmer R, Milka G, Paulson JC (1992) A synthetic sialic acid analogue is recognized by influenza C virus as a receptor determinant but is resistant to the receptor-destroying enzyme. J Biol Chem 267: 12501–12506.
144.
Herscovics A, Orlean P (1993) Glycoprotein biosynthesis in yeast. FASEB J 7: 540–550.
145.
Higgins E, Zhuang DL, Brockhausen I, Siminovitch K, Dennis JW (1991) Aberrant O-linked oligosaccharide biosynthesis in lymphocytes and platelets from patients with the Wiskott-Aldrich syndrome. J Biol Chem 266: 6280–6290.
146.
Hirohashi S, Ino Y, Kodama T, Shimosato Y (1984) Distribution of blood group antigens A, B, H, and I(Ma) in mucus-producing adenocarcinoma of human lung. J Natl Cancer Inst 72: 1299–1305.
147.
Hirschberg CB, Snider MB (1987) Topography of glycosylation in the rough endoplasmic reticulum and Golgi apparatus. Annu Rev Biochem 56: 63–87.
148.
Hirschberg CB (1997) Transporters of nucleotide sugars, nucoleotide sulfate and ATP on the Golgi apparatus: Where next? Glycobiology 7: 169–171.
149.
Ho JJL, Siddiki B, Kim YS (1995) Association of Sialyl-Lewisa and Sialyl-Lewisx with MUC-1 apomucin in a pancreatic cancer cell line. Cancer Res 55: 3659–3663.
150.
Hoff S, Matsushita Y, Ota DM, Cleary KR, Yamori T, Hakomori SI, Irimura T (1989) Increased expression of sialyl-dimeric Lex antigen in liver metastases of human colorectal carcinoma. Cancer Res 49: 6883–6888.
151.
Homa FL, Hollanders T, Lehman DJ, Thomsen DR, Elhammer AP (1993) Isolation and expression of a cDNA clone encoding a bovine UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase. J Biol Chem 268: 12609–12616.
152.
Hoskins L (1978) Degradation of mucus glycoproteins in the gastrointestinal tract; in Horowitz M, Pigman W (eds): The Glycoconjugates. New York, Academic Press, vol 2, pp 235–253.
153.
Hounsell EF, Lawson AM, Feeney J, Gooi HC, Pickering NJ, Stoll MS, Lui SC, Feizi T (1985) Structural analysis of the O-glycosidically linked core region oligosaccharides of human meconium glycoproteins which express oncofetal antigens. Eur J Biochem 148: 367–377.
154.
Hull E, Sarkar M, Spruijt MP, Hoppener JW, Dunn R, Schachter H (1991) Organization and localization to chromosome 5 of the human UDP-N-acetylglucosamine:alpha-3-D- mannoside beta-1,2-N-acetylglucosaminyltransferase I gene. Biochem Biophys Res Commun 176: 608–615.
155.
Hutchinson WL, Du M-Q, Johnson PJ, Williams R (1991) Fucosyltransferases: Differential plasma and tissue alterations in hepatocellular carcinoma and cirrhosis. Hepatology 13: 683–688.
156.
Idikio H, Manickavel V (1991) Lewis blood group antigens (a and b) in human breast tissues. Cancer 68: 1303–1308.
157.
Ihara Y, Nishikawa A, Tohma T, Soejima H, Niikawa N, Taniguchi N (1993) cDNA cloning, expression, and chromosomal localization of human N-acetylglucosaminyltransferase III (GnT-III). J Biochem 113: 692–698.
158.
Ikematsu S, Kaname T, Ozawa M, Yonezawa S, Sato E, Uehara F, Obama H, Yamamura K, Muramatsu T (1993) Transgenic mouse lines with ectopic expression of α1,3-galactosyltransferase: Production and characteristics. Glycobiology 3: 575–580.
159.
Inoue M, Ton S, Ogawa H, Tanizawa O (1991) Expression of Tn and sialyl-Tn antigens in tumor tissues of the ovary. Am J Clin Pathol 96: 711–716.
160.
Ioannides C, Fisk B, Jerome K, Irimura T, Wharton J, Finn O (1993) Cytotoxic T cells from ovarian malignant tumors can recognize polymorphic epithelial mucin core peptides. J Immunol 151: 3693–3703.
161.
Ioffe E, Stanley P (1994) Mice lacking N-acetylglucosaminyltransferase I activity die at mid-gestation, revealing an essential role for complex or hybrid N-linked carbohydrates. Proc Natl Acad Sci USA 91: 728–732.
162.
Ioffe E, Liu Y, Stanley P (1997) Complex N-glycans in Mgat1 null preimplantation embryos arise from maternal Mgat1 RNA. Glycobiology 7: 913–919.
163.
Iozzo R (1985) Proteoglycans: Structure, formation and role in neoplasia. Lab Invest 53: 373–396.
164.
Ito H, Hiraiwa N, Sawada-Kasugai M, Akamatsu S, Tachikawa T, Kasai Y, Akiyama S, Ito K, Takagi H, Kannagi R (1997) Altered mRNA expression of specific molecular species of fucosyl- and sialyl-transferases in human colorectal tissues. Int J Cancer 71: 556–564.
165.
Itzkowitz SH, Bloom EJ, Kokal WA, Modin G, Hakomori SI, Kim YS (1990) Sialosyl-Tn: A novel mucin antigen associated with prognosis in colorectal cancer patients. Cancer 66: 1960–1966.
166.
Itzkowitz SH, Young E, Dubois D, Harpaz N, Bodian C, Chen A, Sachar DB (1996) Sialosyl-Tn antigen is prevalent and precedes dysplasia in ulcerative colitis: A retrospective case-control study. Gastroenterology 110: 694–704.
167.
Jaeken J, Carchon H, Stibler H (1993) The carbohydrate-deficient glycoprotein syndromes: Pre-Golgi and Golgi disorders? Glycobiology 3: 423–428.
168.
Jaeken J, Schachter H, Carchon H, De Cock P, Coddeville B, Spik G (1994) Carbohydrate deficient glycoprotein syndrome type II: A deficiency in Golgi localised N-acetylglucosaminyltransferase II. Arch Dis Child 71: 123–127.
169.
Jass J, Roberton A (1994) Colorectal mucin histochemistry in health and disease: A critical review. Pathol Int 44: 487–504.
170.
Jass J, Allison L, Edgar S (1995) Distribution of sialosyl Tn and Tn antigens within normal and malignant colorectal epithelium. J Pathol 176: 143–149.
171.
Jensen JW, Schutzbach JS (1981) The biosynthesis of oligosaccharide-lipids: Partial purification and characterization of mannosyltransferase II. J Biol Chem 256: 12899–12904.
172.
Jensen JW, Schutzbach JS (1982) The biosynthesis of oligosaccharide-lipids: Activation of mannosyltransferase II by specific phospholipids. J Biol Chem 257: 9025–9029.
173.
Jensen JW, Schutzbach JS (1984) Activation of mannosyltransferase II by nonbilayer phospholipids. Biochemistry 23: 1115–1119.
174.
Jensen JW, Schutzbach JS (1988) Modulation of dolichyl-phosphomannose synthase activity by changes in the lipid environment of the enzyme. Biochemistry 27: 6315–6320.
175.
Jensen JW, Schutzbach JS (1989) Phospholipase-induced modulation of dolichyl-phosphomannose synthase activity. Biochemistry 28: 851–855.
176.
Jerome KR, Domenech N, Finn OJ (1993) Tumor-specific cytotoxic T cell clones from patients with breast and pancreatic adenocarcinoma recognize EBV-immortalized B cells transfected with polymorphic epithelial mucin complementary DNA. J Immun 151: 1654–1662.
177.
Johnson D, Frame M, Ligas M, Cross A, Stow N (1988) Herpes simplex virus immunoglobulin G Fc receptor activity depends on a complex of two viral glycoproteins gE and gI. J Virol 62: 1347–1354.
178.
Johnston DS, Shaper JH, Shaper NL, Joziasse DH, Wright WW (1995) The gene encoding murine alpha 1,3-galactosyltransferase is expressed in female germ cells but not in male germ cells. Dev Biol 171: 224–232.
179.
Jorgensen T, Berner A, Kaalhus A, Tveter KJ, Danielsen HE, Bryne M (1995) Upregulation of the oligosaccharide sialyl Lewisx: A new prognostic parameter in metastatic prostate cancer. Cancer Res 55: 1817–1819.
180.
Joziasse DH, Shaper JH, Jabs EW, Shaper NL (1991) Characterization of an α1-3-galactosyltransferase homologue on human chromosome 12 that is organized as a processed pseudogene. J Biol Chem 266: 6991–6998.
181.
Ju TZ, Chen HL, Gu JX (1995) Regulation of N-acetylglucosaminyltransferase V by protein kinases. Glycoconj J 12: 767–772.
182.
Kanani A, Sutherland DR, Fibach E, Matta KL, Hindenburg A, Brockhausen I, Kuhns W, Taub RN, van den Eijnden DH, Baker MA (1990) Human leukemic myeloblasts and myeloblastoid cells contain the enzyme cytidine 5′-monophosphate-N-acetylneuraminic acid: Galβ1-3 GalNAcα(2-3) sialyltransferase. Cancer Res 50: 5003–5007.
183.
Kaneko M, Nishihara S, Shinya N, Kudo T, Iwasaki H, Sano T, Okubo Y, Narimatsu H (1997) Wide variety of point mutations in the H gene of Bombay and para-Bombay individuals that inactivate H-enzyme. Blood 90: 839–849.
184.
Kang R, Saito H, Ihara Y, Miyoshi E, Koyama N, Sheng Y, Taniguchi N (1996) Transcriptional regulation of the N-acetylglucosaminyltransferase V gene in human bile duct carcinoma cells (HuCC-T1) is mediated by Ets-1. J Biol Chem 271: 26706–26712.
185.
Karlsson G, Butters T, Dwek R, Platt F (1993) Effects of the imino sugar N-butyldeoxynojirimycin on the N-glycosylation of recombinant gp120. J Biol Chem 268: 570–576.
186.
Kean EL (1992) Studies on the activation by dolichol-P-mannose of the biosynthesis of GlcNAc-P-P-dolichol and the topography of the GlcNAc-transferases concerned with the synthesis of GlcNAc-P-P-dolichol and (GlcNAc)2-P-P-ddolichol: A review. Biochem Cell Biol 70: 413–421.
187.
Kelly RJ, Ernst LK, Larsen RD, Bryant JG, Robinson JS, Lowe JB (1994) Molecular basis for H blood group deficiency in Bombay (Oh) and para-Bombay individuals. Proc Natl Acad Sci USA 91: 5843–5847.
188.
Kessel D, Sykes E, Henderson M (1977) Glyosyltransferase levels in tumors metastatic to liver and in uninvolved liver tissue. J Natl Cancer Inst 59: 29–32.
189.
Kim YS, Byrd JC (1984) Ulcerative colitis: A specific mucin defect? Gastroenterology 87: 1193–1195.
190.
Kim YS, Itzkowitz SH, Yuan M, Chung Y, Satake K, Umeyama K, Hakomori S (1988) Lex and Ley antigen expression in human pancreatic cancer. Cancer Res 48: 475–482.
191.
Kim YS, Gum J, Brockhausen I (1996a) Mucin glycoproteins in neoplasia. Glycoconj J 13: 693–707.
192.
Kim YJ, Kim KS, Kim SH, Kim JH, Choe IS, Tsuji S, Lee YC (1996b) Molecular cloning and expression of human Gal beta, 1,3GalNAc alpha 2,3-sialyltransferase (hSTGal II). Biochem Biophys Res Commun 228: 324–327.
193.
Kim Y, Varki A (1997) Perspectives on the significance of altered glycosylation of glycoproteins in cancer. Glycoconj J 14: 569–576.
194.
King MJ, Chan A, Roe R, Warren BF, Dell A, Morris HR, Bartolo CC, Durdey P, Corfield AP (1994) Two different glycosyltransferase defects that result in GalNAcα-O-peptide (Tn) expression. Glycobiology 4: 267–269.
195.
Kobayashi H, Terao T, Kawashima Y (1992) Serum sialyl Tn as an independent predictor of poor prognosis in patients with epithelial ovarian cancer. J Clin Oncol 10: 95–101.
196.
Koenderman AH, Koppen PL, van den Eijnden DH (1987a) Biosynthesis of polyactosaminoglycans. Eur J Biochem 166: 199–208.
197.
Koenderman A, Wijermans P, van den Eijnden D (1987b) Changes in the expression of N-acetylglucosaminyltransferase III, IV, V associated with the differentiation of HL60 cells. FEBS Lett 222: 42–46.
198.
Koike C, Kannagi R, Takuma Y, Akutsu F, Hayashi S, Hiraiwa N, Kadomatsu K, Muramatsu T, Yamakawa H, Nagui T, Kobayashi S, Okada H, Nakashima I, Uchida K, Yokoyama I, Takagi H (1996) Introduction of α(1,2)-fucosyltransferase and its effect on α-Gal epitopes in transgenic pig. Xenotransplantation 3: 81–86.
199.
Kojima N, Handa K, Newman W, Hakomori SI (1992) Inhibition of selectin-dependent tumor cell adhesion to endothelial cells and platelets by blocking O-glycosylation of these cells. Biochem Biophys Res Commun 182: 1288–1295.
200.
Kojima N, Yoshida Y, Tsuji S (1995) A developmentally regulated member of the sialyltransferase family (ST8Sia II, STX) is a polysialic acid synthase. FEBS Lett 373: 119–122.
201.
Kominato Y, Tsuchiya T, Hata N, Takizawa H, Yamamoto F (1997) Transcription of human ABO histo-blood group genes is dependent upon binding of transcription factor CBF/NF-Y to minisatellite sequence. J Biol Chem 272: 25890–25898.
202.
Kornfeld R, Kornfeld S (1985) Assembly of asparagine-linked oligosaccharides. Annu Rev Biochem 54: 631–664.
203.
Kotera Y, Fontenot J, Pecher G, Metzgar RS, Finn OJ (1994) Humoral immunity against a tandem repeat epitope of human mucin MUC1 in sera from breast, pancreatic and colon cancer patients. Cancer Res 54: 2856–2860.
204.
Koyama N, Miyoshi E, Ihara Y, Kang R, Nishikawa A, Taniguchi N (1996) Human N-acetylglucosaminyltransferase III gene is transcribed from multiple promoters. Eur J Biochem 238: 853–861.
205.
Krasnewich DM, Holt GD, Brantly M, Skovby F, Redwine J, Gahl WA (1995) Abnormal synthesis of dolichol-linked oligosaccharides in carbohydrate-deficient glycoprotein syndrome. Glycobiology 5: 503–510.
206.
Krusius T, Reinhold V, Margolis R, Margolis R (1987) Structural studies on sialylated and sulfated O-glycosidic mannose-linked oligosaccharides in the chondroitin sulfate proteoglycan of brain. Biochem J 245: 229–234.
207.
Kuan SF, Byrd JC, Basbaum C, Kim YS (1989) Inhibition of mucin glycosylation by aryl-N-acetyl-α-galactosaminides in human colon cancer cells. J Biol Chem 264: 19271–19277. Kubushiro K, Tsukazaki K, Sakuma Y, Akiba Y, Sakayori M, Aoki R, Yazawa S, Nozawa S (1995) Expression mechanism of human uterine endometrial cancer-specific fucosylated carbohydrate chains: Aberrant α1-4-fucosyltransferases in uterine endometrial cancer-derived cell lines with type 1 carbohydrate chain. Int J Oncol 6: 93–97.
208.
Kuhns W, Pann C (1972) Differentiation of HeLa cells with respect to blood group H antigen. Nature New Biol 96: 22–24.
209.
Kuhns W, Oliver R, Watkins W, Greenwell P (1980) Leukemia-induced alterations of serum glycosyltransferase enzymes. Cancer Res 40: 268–275.
210.
Kuhns W, Rutz V, Paulsen H, Matta KL, Baker MA, Barner M, Granovsky M, Brockhausen I (1993) Processing O-glycan core 1, Galβ1-3GalNAcα-R. Specificities of core 2 UDP-GlcNAc:Galβ1-3GalNAc-R β6-N-acetylglucosaminyltransferase and CMP-SA: Galβ1- 3GalNAc-R α3-sialyltransferase. Glycoconj J 10: 381–394.
211.
Kuhns W, Jain R, Matta K, Paulsen H, Baker M, Geyer R, Brockhausen I (1995) Characterization of a novel mucin sulfotransferase activity synthesizing sulfated O-glycan core 1,3-sulfate-Gal-Beta1-3GalNAc-alpha-R. Glycobiology 5: 689–697.
212.
Kukuruzinska MA, Bergh MLE, Jackson BJ (1987) Protein glycosylation in yeast. Annu Rev Biochem 56: 915–944.
213.
Kumar R, Camphausen RT, Sullivan FX, Cumming DA (1996) Core 2 β-1, 6-N-acetylglucosaminyltransferase enzyme activity is critical for P-selectin glycoprotein ligand-1 binding to P-selectin. Blood 88: 3872–3879.
214.
Kurosaka A, Nakajima H, Funakoshi J, Matsuyama M, Nagayo T, Yamashina I (1983) Structures of the major oligosaccharides from a human rectal adenocarcinoma glycoprotein. J Biol Chem 258: 11594–11598.
215.
Kurosaka A, Funakoshi I, Matsuyama M, Nagayo T, Yamashina I (1985) UDP-GalNAc:GalNAc-mucin alpha-N-acetylgalactosamine transferase activity in human intestinal cancerous tissue. FEBS Lett 190: 259–262.
216.
Kurosawa N, Hamamoto T, Lee YC, Nakaoka T, Kojima N, Tsuji S (1994a) Molecular cloning and expression of GalNAc alpha 2,6-sialyltransferase. J Biol Chem 269: 1402–1409.
217.
Kurosawa N, Kojima N, Inoue M, Hamamoto T, Tsuji S (1994b) Cloning and expression of Gal beta 1,3GalNAc-specific GalNAc alpha 2,6-sialyltransferase. J Biol Chem 269: 19048–19053.
218.
Kurosawa N, Hamamoto T, Inoue M, Tsuji S (1995) Molecular cloning and expression of chick Gal beta 1,3GalNAc alpha 2,3-sialyltransferase. Biochim Biophys Acta 1244: 216–222.
219.
Lamblin G, Boersma A, Klein A, Roussel P, van Halbeek H, Vliegenthart JFG (1984) Primary structure determination of five sialylated oligosaccharides derived from bronchial mucas glycoproteins of patients suffering from cystic fibrosis. The occurrence of the NeuAcα(2-3)Galβ(1-4)[Fucα(1-3)]GlcNAcβ(1-) structural element revealed by 500-MHz 1H NMR spectroscopy. J Biol Chem 259: 9051–9058.
220.
Larsen RD, Ernst LK, Nair RP, Lowe JB (1990) Molecular cloning, sequence and expression of a human GDP-L-fucose:beta-D-galactoside 2-alpha-L-fucosyltransferase cDNA that can form the H blood group antigen. Proc Natl Acad Sci USA 87: 6674–6678.
221.
Lazatin J, Glick M, Scanlin T (1994) Fucosylation in cystic fibrosis airway epithelial cells. Glycosylation Dis 1: 263–270.
222.
Lee J, Ro J, Sahin A, Hong W, Brown B, Mountain C, Hittelman W (1991) Expression of blood group antigen A – A favorable prognostic factor in non-small cell lung cancer. N Engl J Med 324: 1084–1090.
223.
Lee YC, Kurosawa N, Hamamoto T, Nakoaka T, Tsuji S (1993) Molecular cloning and expression of Gal-beta-1,3GalNAc-alpha-2,3-sialyltransferase from mouse brain. Eur J Biochem 216: 377–385.
224.
Lee YC, Kojima N, Wada E, Kurosawa N, Nakaoka T, Hamamoto T, Tsuji S (1994) Cloning and expression of cDNA for a new type of Galβ1,3GalNAc α2,3-sialyltransferase. J Biol Chem 269: 10028–10033.
225.
Lemarer N, Laudet V, Svensson EC, Cazlaris H, Van Hille B, Lagrou C, Stehelin D, Montreuil J, Verbert A, Delannoy P (1992) The c-Ha-ras oncogene induces increased expression of β-galactoside α-2,6 sialyltransferase in rat fibroblast (FR3T3) cells. Glycobiology 2: 49–56.
226.
Leonard C, Spellman M, Riddle L, Harris R, Thomas J, Gregory T (1990) Assignment of intrachain disulfide bonds and characterization of potential glycosylation sites of the type 1 recombinant human immunodeficiency virus envelope glycoprotein (gp120) expressed in Chinese hamster ovary cells. J Biol Chem 265: 10373–10382.
227.
Li F, Wilkins PP, Crawley S, Weinstein J, Cummings RD, McEver RP (1996) Posttranslational modifications of recombinant P-selectin glycoprotein ligand-1 required for binding to P- and E-selectin. J Biol Chem 271: 3255–3264.
228.
Lidholt K, Weinke JL, Kiser CS, Lugemwa FN, Bame KJ, Cheifetz S, Massague J, Lindahl U, Esko JD (1992) A single mutation affects both N-acetylglucosaminyltransferase and glucuronosyltransferase activities in heparan sulfate biosynthesis. Proc Natl Acad Sci USA 89: 2267–2271.
229.
Liu CK, Schmied R, Waxman S (1982) Characterization of galactosyltransferase released from human hepatoma cells. Enzyme 28: 258–267.
230.
Liukkonen J, Haataja S, Tikaanan K, Kelm S, Finne J (1992) Identification of N-acetylneuraminyl α2-3 poly-N-acetyllactosamine glycans as the receptors of sialic acid binding Streptococcus suis strains. J Biol Chem 267: 21105–21111.
231.
Lloyd KO, Burchell J, Kudryashov V, Yin BWT, Taylor-Papadimitriou J (1996) Comparison of O-linked carbohydrate chains in MUC-1 mucin from normal breast epithelial cell lines and breast carcinoma cell lines. J Biol Chem 271: 33325–33334.
232.
Lo-Guidice J, Wieruszeski J, Lemóine J, Verbert A, Roussel P, Lamblin G (1994) Sialylation and sulfation of the carbohydrate chains in respiratory mucins from a patient with cystic fibrosis. J Biol Chem 269: 18794–18813.
233.
Lo-Guidice J, Perini J, Lafitte J, Ducourouble M, Roussel P, Lamblin G (1995) Characterization of a sulfotransferase from human airways responsible for the 3-O-sulfation of terminal galactose in N-acetyllactosamine-containing mucin carbohydrate chains. J Biol Chem 270: 27544–27550.
234.
Louisot P, Levrat C (1973) A new pathogenic hypothesis for cystic fibrosis: Hyperactivity of glycosyltransferases at microsomic level. Clin Chim Acta 48: 373–376.
235.
Lowe JB, Kukowska-Latallo JF, Nair RP, Larsen RD, Marks RM, Macher BA, Kelly RJ, Ernst LK (1991) Molecular cloning of a human fucosyltransferase gene that determines expression of the Lewis X and VIM-2 epitopes but not ELAM-1-dependent cell adhesion. J Biol Chem 266: 17467–17477.
236.
Ma J, Qian R, Rausa FM, Colley KJ (1997) Two naturally occurring α2,6-sialyltransferase forms with a single amino acid change in the catalytic domain differ in their catalytic activity and proteolytic processing. J Biol Chem 272: 672–679.
237.
Malhotra R, Wormald MR, Rudd PM, Fischer PB, Dwek RA, Sim RB (1995) Glycosylation changes of IgG associated with rheumatoid arthritis can activate complement via the mannose-binding protein. Nat Med 1: 237–243.
238.
Maly P, Thall A, Petryniak B, Rogers CE, Smith PL, Marks RM, Kelly RJ, Gersten KM, Cheng G, Saunders TL, Camper SA, Camphausen RT, Sullivan FX, Isogai Y, HIndsgaul O, von Andrian UH, Lowe JB (1996) The alpha(1,3)fucosyltransferase Fuc-TVII controls leukocyte trafficking through an essential role in L-, E-, and P-selectin ligand biosynthesis. Cell 86: 643–653.
239.
Mandon E, Kempner E, Ishihara M, Hirschberg C (1994) A monomeric protein in the Golgi membrane catalyzes both N-deacetylation and N-sulfation of heparan sulfate. J Biol Chem 269: 11729–11733.
240.
Manzi AE, Sjoberg ER, Diaz S, Varki A (1990) Biosynthesis and turnover of O-acetyl and N-acetyl groups in the gangliosides of human melanoma cells. J Biol Chem 265: 13091–13103.
241.
Marchase RB, Bounelis P, Brumley LM, Dey N, Browne B, Auger D, Fritz TA, Kulesza P, Bedwell DM (1993) Phosphoglucomutase in Saccharomyces cerevisiae is a cytoplasmic glycoprotein and the acceptor for a Glc-phosphotransferase. J Biol Chem 268: 8341–8349. Markwell MAK, Paulson JC (1980) Sendai virus utilizes specific sialyloligosaccharides as host cell receptor determinants. Proc Natl Acad Sci USA 77: 5693–5697.
242.
Martinez J, Palascak JE, Kwasniak D (1978) Abnormal sialic acid content of the dysfibrinogenemia associated with liver disease. J Clin Invest 61: 535–538.
243.
Matern H, Bolz R, Matern S (1990) Isolation and characterization of UDP-glucose dolichyl-phosphate glucosyltransferase from human liver. Eur J Biochem 190: 99–105.
244.
Matsumoto K, Maeda Y, Kato S, Yuki H (1994) Alteration of asparagine-linked glycosylation in serum transferrin of patients with hepatocellular carcinoma. Clin Chim Acta 224: 1–8.
245.
Matsushita Y, Nakamori S, Seftor EA, Hendrix MJC, Irimura T (1991) Human colon carcinoma cells with increased invasive capacity obtained by selection for sialyl-dimeric Lex antigen. Exp Cell Res 196: 20–25.
246.
McMahon RFT, Jones CJP, Dutt S, Stoddart RW (1994) Altered oligosaccharide expression in ulcerative colitis with increasing grades of inflammation. Glycosyl Dis 1: 235–245.
247.
Metzgar RS, Rodriguez N, Finn OJ, Lan MS, Daasch VN, Fernstein PD, Meyers WC, Sindelar WF, Sandler RS, Seigler HF (1984) Detection of a pancreatic cancer associated antigen (DU-PAN-2 antigen) in serum and ascites of patients with adenocarcinoma. Proc Natl Acad Sci USA 81: 5242–5246.
248.
Metzler M, Gertz A, Sarkar M, Schachter H, Schrader JW, Marth J (1994) Complex asparagine-linked oligosaccharides are required for morphogenic events during postimplantation development. EMBO J 13: 2056–2065.
249.
Meurer JA, Naylor JM, Baker CA, Thomsen DR, Homa FL, Elhammer AP (1995) cDNA cloning, expression, and chromosomal localization of a human UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase. J Biochem 118: 568–574.
250.
Miller D, Macek B, Shur B (1992) Complementarity between sperm surface β1-4 galactosyltransferase and egg coat ZP3 mediates sperm-egg binding. Nature 357: 589–593.
251.
Minamida S, Aoki K, Natsuka S, Omichi K, Fukase K, Kusomoto S, Hase S (1996) Detection of UDP-D-xylose: Alpha-D-xyloside alpha 1-3xylosyltransferase activity in human hepatoma cell line HepG2. J Biochem 120: 1002–1006.
252.
Miyake M, Zenita K, Tanaka O, Okada Y, Kannagi R (1988) Stage-specific expression of SEA-1-related antigens in the developing lung of human embryos and its relationship to the distribution of these antigens in lung cancers. Cancer Res 48: 7150–7158.
253.
Miyake M, Kohno N, Nudelman E, Hokomori S (1989) Human IgG3 monoclonal antibody directed to an unbranched repeating type 2 chain (Galβ1-4GlcNAcβ1-3Galβ1-4GlcNAcβ1-3Galβ1-R) which is highly expressed in colonic and hepatocellular carcinoma. Cancer Res 49: 5689–5695.
254.
Miyake M, Taki T, Hitomi S, Hakomori S (1992) Correlation of expression of H/Ley/Leb antigens with survival in patients with carcinoma of the lung. N Engl J Med 327: 14–18.
255.
Miyoshi E, Nishikawa A, Ihara Y, Gu J, Sugiyama T, Hayashi N, Fusamoto H, Kamada T, Taniguchi N (1993) N-acetylglucosaminyltransferase III and V messenger RNA levels in LEC rats during hepatocarcinogenesis. Cancer Res 53: 3899–3902.
256.
Mizuochi T, Nishimura R, Derappe C, Taniguchi T, Hamamoto T, Mochizuki M, Kobata A (1983) Structures of the asparagine-linked sugar chains of human chorionic gonadotropin produced in choriocarcinoma. J Biol Chem 258: 14126–14129.
257.
Mizuochi T, Spellman M, Larkin M, Solomon J, Basa L, Feizi T (1988) Carbohydrate structures of the human immunodeficiency virus (HIV) recombinant envelope glycoprotein gp120 produced in Chinese hamster ovary cells. Biochem J 254: 599–603.
258.
Mizuochi T, Matthews T, Kato M, Hamako J, Titani K, Solomon J, Feizi T (1990) Diversity of oligosaccharide structures on the envelope glycoprotein gp120 of human immunodeficiency virus from the lymphoblastoid cell line H9. J Biol Chem 265: 8519–8524.
259.
Moolenaar CECK, Muller EJ, Schol DJ, Figdor CG, Bock E, Bitter-Suermann D, Michalides RJAM (1990) Expression of neural cell adhesion molecule-related sialoglycoprotein in small cell lung cancer and neuroblastoma cell lines H69 and CHP-212. Cancer Res 50: 1102–1106.
260.
Morel-Kopp MC, Kaplan C, Proulle V, Jallu V, Melchior C, Peyruchaud O, Aurousseau MH, Kieffer N (1997) A three amino acid deletion in glycoprotein IIIa is responsible for type I Glanzmann’s thrombasthenia: Importance of residues Ile325Pro326Gly327 for beta3 integrin subunit association. Blood 90: 669–677.
261.
Morita H, Kettlewell MGW, Jewll DP, Kent PW (1993) Glycosylation and sulphation of colonic mucus glycoproteins in patients with ulcerative colitis and in healthy subjects. Gut 34: 926–932.
262.
Muchmore EA, Varki NM, Fukuda M, Varki A (1987) Developmental regulation of sialic acid modifications in rat and human colon. FASEB J 1: 229–235.
263.
Mulligan M, Paulson J, DeFrees S, Zheng Z, Lowe J, Ward P (1993a) Protective effects of oligosaccharides in P-selectin-dependent lung injury. Nature 364: 149–151.
264.
Mulligan MS, Lowe JB, Larsen RD, Paulson J, Zheng Z, DeFrees S, Maemura K, Fukuda M, Ward PA (1993b) Protected effects of sialylated oligosaccharides in immune complex-induced acute lung injury. J Exp Med 178: 623–631.
265.
Nagai K, Ihara Y, Wada Y, Taniguchi N (1997) N-glycosylation is requisite for the enzyme activity and Golgi retention of N-acetylglucosaminyltransferase III. Glycobiology 7: 769–776.
266.
Nakano T, Matsui T, Ota T (1996) Benzyl-α-GalNAc inhibits sialylation of O glycosidic sugar chains on CD44 and enhances experimental metastatic capacity in B16B L6 melanoma cells. Anticancer Res 16: 3577–3584.
267.
Nakayama J, Fukuda MN, Fredette B, Ranscht B, Fukuda M (1995) Expression cloning of a human polysialyltransferase that forms the polysialylated neural cell adhesion molecule present in embryonic brain. Proc Natl Acad Sci USA 92: 7031–7035.
268.
Narasimhan S, Schachter H, Rajalakshmi S (1988) Expression of N-acetylglucosaminyltransferase III in hepatic nodules during rat liver carcinogenesis promoted by orotic acid. J Biol Chem 263: 1273–1281.
269.
Nehrke K, Hagen KGT, Hagen FK, Tabak LA (1997) Charge distribution of flanking amino acids inhibits O-glycosylation of several single-site acceptors in vivo. Glycobiology 7: 1053–1060.
270.
Nilsson O (1992) Carbohydrate antigens in human lung carcinomas. APMIS 100(suppl 27V): 149–161.
271.
Nishimori I, Johnson NR, Sanderson SD, Perini F, Mountjoy K, Cerny L, Gross ML, Hollingsworth MA (1994) Influence of acceptor substrate primary amino acid sequence on the activity of human UDP-N-acetylgalactosamine: polypeptide N-acetylgalactosaminyltransferase. Studies with the MUC1 tandem repeat. J Biol Chem 269: 16123–16130.
272.
Nishimura R, Endo Y, Tanabe K, Ashitaka Y, Tojo S (1981) The biochemical properties of urinary human chorionic gonadotropin from the patients with trophoblastic diseases. J Endocrinol Invest 4: 349–358.
273.
Nishio Y, Warren C, Buczek-Thomas JA, Rulfs J, Koya D, Aiello LP, Feener E, Miller TB, Dennis JW, King GL (1995) Identification and characterization of a gene regulating enzymatic glycosylation which is induced by diabetes and hyperglycemia specifically in rat cardiac tissue. J Clin Invest 96: 1759–1767.
274.
Noda K, Miyoshi E, Uozumi N, Gao CX, Suzuki K, Hayashi N, Hori M, Taniguchi N (1998) High expression of alpha-1-6fucosyltransferase during rat heptocarcinogenesis. Int J Cancer 75: 444–450.
275.
O’Connell BC, Hagen FK, Tabak LA (1992) The influence of flanking sequence on the O-glycosylation of threonine in vitro. J Biol Chem 267: 25010–25018.
276.
O’Hanlon TP, Lau KM, Wang XC, Lau JTY (1989) Tissue-specific expression of β-galactoside α-2,6sialyltransferase. J Biol Chem 264: 17389–17394.
277.
O’Keeffe ET, Mordick T, Bell JE (1980) Bovine galactosyltransferase: Interaction with α-lactalbumin and the role of αlactalbumin in lactose synthase. Biochemistry 19: 4962–4966. Oesterling JE (1991) Prostate specific antigen: A critical assessment of the most useful tumor marker for adenocarcinoma of the prostate. J Urol 145: 907–923.
278.
Ogata S, Ho I, Chen A, Dubois D, Maklansky J, Singhal A, Hakomori S, Itzkowitz S (1995) Tumor associated sialylated antigens are constitutively expressed in normal human colonic mucosa. Cancer Res 55: 1869–1874.
279.
Ogawa J, Inoue H, Koide S (1996) Expression of α1-3-fucosyltransferase type IV and VII genes is related to poor prognosis in lung cancer. Cancer Res 56: 325–359.
280.
Oguri S, Minowa M, Ihara Y, Taniguchi N, Ikenaga H, Takeuchi M (1997) Purification and characterization of UDP-N-acetylglucosamine: α1,3-D-mannoside β1,4 N-acetylglucosaminyltransferase (N-acetylglucosaminyltransferase IV) from bovine small intestine. J Biol Chem 272: 22721–22727.
281.
Ohno M, Nishikawa A, Koketsu M, Taga H, Endo Y, Hada T, Higashino K, Taniguchi N (1992) Enzymatic basis of sugar structures of α-fetoprotein in hepatoma and hepatoblastoma cell lines: Correlation with activities of α1-6 fucosyltransferase and N-acetylglucosaminyltransferases III and V. Int J Cancer 51: 315–317.
282.
Ohkura T, Fukushima K, Kurisaki A, Sagami H, Ogura K, Ohno K, Hara-Kuge S, Yamashita K (1997) A partial deficiency of dehydrodolichol reduction is a cause of carbohydrate-deficient glycoprotein syndrome type I. J Biol Chem 272: 6868–6875.
283.
Olofsson S (1992) Carbohydrates in herpesviruses infection. APMIS 100(suppl 27): 84–95.
284.
Orntoft TF, Wolf H, Watkins W (1988) Activity of the human blood group ABO, Se, H, Le, and X gene-encoded glycosyltransferases in normal and malignant bladder urothelium. Cancer Res 48: 4427–4433.
285.
Orntoft T, Harving N, Langkilde N (1990) O-linked mucin-type glycoproteins in normal and malignant colon mucosa: Lack of T antigen expression and accumulation of Tn and sialosyl-Tn antigens in carcinomas. Int J Cancer 45: 666–672.
286.
Orntoft TF (1992) Carbohydrate changes in bladder carcinoma. APMIS 100(suppl 27): 181–187.
287.
Orntoft TF, Meldgaard P, Pedersen B, Wolf H (1996) The blood group ABO gene transcript is down-regulated in human bladder tumors and growth-stimulated urothelial cell lines. Cancer Res 56: 1031–1036.
288.
Ou WJ, Cameron PH, Thomas DY, Bergeron JJM (1993) Association of folding intermediates of glycoproteins with calnexin during protein maturation. Nature 364: 771–776.
289.
Pancake S, Holt G, Mellouk S, Hoffman S (1992) Malaria sporozoites and circumsporozoite proteins bind specifically to sufated glycoconjugates. J Cell Biol 117: 1351–1357.
290.
Panneerselvam K, Freeze HH (1996) Mannose corrects altered N-glycosylation in carbohydrate-deficient glycoprotein syndrome fibroblasts. J Clin Invest 97: 1478–1487.
291.
Paraskeva C, Hague A, Rooney N, Williams AC, Harper SJ, Hanlon KA, Atkinsons RJ, Corfield A (1992) A single human colonic adenoma cell line can be converted in vitro to both a colorectal adenocarcinoma and a mucinous carcinoma. Int J Cancer 51: 661–664.
292.
Parekh RB, Dwek RA, Sutton BJ, Fernandes DL, Leung A, Stanworth D, Rademacher TW, Mizuochi T, Taniguchi T, Matsuta K, Takeuchi F, Nagano Y, Miyamota T, Kobata A (1985) Association of rheumatoid arthritis and primary osteoarthritis with changes in the glycosylation pattern of total serum IgG. Nature 316: 452–457.
293.
Parker N, Tsai HH, Ryder SD, Raouf AH, Rhodes JM (1995) Increased rate of sialylation of colonic mucin by cultured ulcerative colitis mucosal explants. Digestion 56: 52–56.
294.
Passaniti A, Hart GW (1988) Cell surface sialylation and tumor metastasis. J Biol Chem 263: 7591–7603.
295.
Peerschke EI, Zucker MB, Grant RA, Egan JJ, Johnson MM (1980) Correlation between fibrinogen binding to human platelets and platelet aggregability. Blood 55: 841–847.
296.
Phillips ML, Schwartz BR, Etzioni A, Bayer R, Ochs HD, Paulson JC, Harlan JM (1995) Neutrophil adhesion in leukocyte adhesion deficiency syndrome type 2. J Clin Invest 96: 2898–2906.
297.
Pierce M, Arango J (1986) Rous sarcoma virus-transformed baby hamster kidney cells express higher levels of asparagine linked tri- and tetraantennary glycopeptides containing GlcNAc-β(1-6)Man-α(1-6)Man- and poly-N-acetyllactosamine sequences than baby hamster kidney cells. J Biol Chem 261: 10772–10777.
298.
Piller F, Cartron J-P, Maranduba A, Veyrieres A, Leroy Y, Fournet B (1984) Biosynthesis of blood group I antigens. Identification of a UDP-GlcNAc:GlcNAcβ1-3Gal(–R) β1-6(GlcNAc to Gal) N-acetylglucosaminyltransferase in hog gastric mucosa. J Biol Chem 259: 13385–13390.
299.
Piller F, Piller V, Fox R, Fukuda M (1988) Human T-lymphocytes activation is associated with changes in O-glycan biosynthesis. J Biol Chem 263: 15146–15150.
300.
Piller F, Le Deist F, Weinberg KI, Parkman R, Fukuda M (1991) Altered-O-glycan synthesis in lymphocytes from patients with Wiscott-Aldrich syndrome. J Exp Med 173: 1501–1510.
301.
Platt JL, Lindman BJ, Chen H, Spitalnik SL, Bach FH (1990) Endothelial cell antigens recognized by xenoreactive human natural antibodies. Transplantation 50: 817–822.
302.
Pousset D, Pillet V, Bureaud N, Monsigny M, Piller P (1997) Increased α2,6 sialylation of N-glycans in a transgenic mouse model of hepatocellular carcinoma. Cancer Res 57: 4249–4256.
303.
Powell LD, Paneerselvam K, Vij R, Diaz S, Manzi A, Buist N, Freeze H, Varki A (1994) Carbohydrate-deficient glycoprotein syndrome: Not an N-linked oligosaccharide processing defect, but an abnormality in lipid-linked oligosaccharide biosynthesis? J Clin Invest 94: 1901–1909.
304.
Prieels J, Monnom D, Dolmans M, Beyer TA, Hill RL (1981) Co-purification of the Lewis blood group N-acetylglucosaminide α1-4 fucosyltransferase and N-acetylglucosaminide α1-3 fucosyltransferase from human milk. J Biol Chem 256: 10456–10463.
305.
Prieto PD, Mukerji P, Kelder B, Erney R, Gonzalez D, Yun JS, Smith DF, Moremen KW, Nardelli C, Pierce M, Li Y, Chen X, Wagner TE, Cummings RD, Kopchick JJ (1995) Remodeling of mouse milk glycoconjugates by transgenic expression of a human glycosyltransferase. J Biol Chem 270: 29515–29519.
306.
Rademacher TW, Williams P, Dwek RA (1994) Agalactosyl glycoforms of IgG autoantibodies are pathogenic. Proc Natl Acad Sci USA 91: 6123–6127.
307.
Rademacher TW, Jones RH, Williams PJ (1995) Significance and molecular basis for IgG glycosylation changes in rheumatoid arthritis. Adv Exp Med Biol 376: 193–204.
308.
Raju TS, Ray MK, Stanley P (1995) LEC18, a dominant Chinese hamster ovary glycosylation mutant synthesizes N-linked carbohydrates with a novel core structure. J Biol Chem 270: 30294–30302.
309.
Raju TS, Stanley P (1996) LEC14, a dominant Chinese hamster ovary glycosylation mutant expresses complex N-glycans with a new N-acetylglucosamine residue in the core region. J Biol Chem 271: 7484–7493.
310.
Ramphal R, Carnoy C, Fiebre S, Michalski JC, Houdret N, Lamblin G, Strecker G, Roussel P (1991) Pseudomonas aeruginosa recognizes carbohydrate chains containing type 1(Galβ1-3GlcNAc) or type 2(Galβ1-4GlcNAc) disaccaride units. Infect Immun 59: 700–704.
311.
Raouf A, Tsai H, Parker N, Hoffman J, Walker R, Rhodes J (1992) Sulfation of colonic and rectal mucin in inflammatory bowel disease: Reduced sulfation of rectal mucus in ulcerative colitis. Clin Sci 83: 623–626.
312.
Ravn V, Teglbjaerg CS, Mandel U, Dabelsteen E (1993) The distribution of type 1 chain ABH and related histo-blood group antigens in normal cycling human endometrium. Int J Gynecol Pathol 12: 70–79.
313.
Reid PE, Culling CFA, Dunn WL, Ramey CW, Clay MG (1984) Chemical and histochemical study of normal and diseased human gastrointestinal tract. A comparison between histologically normal colon, colonic tumors, ulcerative colitis and diverticular disease of the colon. Histochem J 16: 235–251.
314.
Reutter W, Stäsche R, Stehling P, Baum O (1997) The biology of sialic acids: Insights into their structure, metabolism and function in particular during viral infection; in Gabius HJ, Gabius S (eds): Glycosciences. Weinheim, Chapman & Hall, pp 245–259.
315.
Roberton A, McKenzie C, Sharfe N, Stubbs L (1993) A glycosulfatase that removes sulfate from mucus glycoprotein. Biochem J 293: 683–689.
316.
Roth J, Wang Y, Eckhardt AE, Hill RL (1994) Subcellular localization of the UDP-N-acetyl-D-galactosamine: polypeptide N-acetylgalactosaminyltransferase-mediated O-glycosylation reaction in the submaxillary gland. Proc Natl Acad Sci USA 91: 8935–8939.
317.
Roth J (1995) Compartmentation of glycoprotein biosynthesis; in Montreuil J, Vliegenthart JFG, Schachter H (eds): Glycoproteins. Amsterdam, Elsevier, pp 287–312.
318.
Röttger S, White J, Wandall HH, Olivo JC, Stark A, Bennett EP, Whitehouse C, Berger EG, Clausen H, Nilsson T (1998) Localization of three human polypeptide GalNAc-transferases in HeLa cells suggests initiation of O-linked glycosylation throughout the Golgi apparatus. J Cell Sci 111: 45–60.
319.
Rossowsky W, Srivastava B (1983) Glycosyl transferase activities in leukemia cells from patients and human leukemic cell lines. Eur J Cancer Clin Oncol 19: 1431–1437.
320.
Roussel P, Lamblin G (1995) Human mucosal mucins in diseases; in Montreuil J, Vliegenthart JFG, Schachter H (eds): Glycoproteins. Amsterdam, Elsevier, pp 351–393.
321.
Rughetti A, Turchi V, Ghetti CA, Scambia G, Panici PB, Roncucci G, Mancuso S, Frati L, Nuti M (1993) Human B-cell immune-response to the polymorphic epithelial mucin. Cancer Res 53: 2457–2459.
322.
Rye PD, Bovin NV, Vlasova EV, Walker RA (1995) Monoclonal antibody LU-BCRU-G7 against a breast tumour-associated glycoprotein recognizes the disaccharides Gal beta 1-3GlcNAc. Glycobiology 5: 385–389.
323.
Saitoh O, Piller F, Fox RI, Fukuda M (1991) T-lymphocytic leukemia expresses complex, branched O-linked oligosaccharides on a major sialoglycoprotein, leukosialin. Blood 77: 1491–1499.
324.
Saitoh O, Wang WC, Lotan R, Fukuda M (1992) Differential glycosylation and cell surface expression of lysosomal membrane glycoproteins in sublines of a human colon cancer exhibiting distinct metastatic potentials. J Biol Chem 267: 5700–5711.
325.
Sawada T, Ho JJL, Chung YS, Sowa M, Kim YS (1994) E-selectin binding by pancreatic tumor cells is inhibited by cancer sera. Int J Cancer 57: 901–907.
326.
Schachter H, Brockhausen I (1992) The biosynthesis of serine(threonine)-N-acetylgalactosamine-linked carbohydrate moieties; in Allen HJ, Kisailus EC (eds): Glycoconjugates. Composition, Structure and Function. New York, Dekker, pp 263–332.
327.
Schachter H (1995) Biosynthesis. Glycosyltransferases involved in the synthesis of N-glycan antennae; in Montreuil J, Vligenthart JFG, Schachter H (eds): Glycoproteins. Amsterdam, Elsevier, pp 153–199.
328.
Schachter H, Chen S, Zhou S, Tan J, Yip B, Sarkar M (1997) Structure and function of the genes encoding N-acetylglucosaminyltransferases which initiate N-glycan antennae. Biochem Soc Trans 25: 875–880.
329.
Schenkman S, Ferguson M, Heise N, Cardoso de Almeida M, Mortara R, Yoshida N (1993) Mucin-like proteins linked to the membrane by glycosylphosphatidylinositol anchor are the major acceptors of sialic acid in a reaction catalyzed by trans-sialidase in metacyclic forms of Trypanosoma cruzi. Mol Biochem Pharmacol 59: 293–304.
330.
Schenkman S, Eichinger D, Pereira M, Nussenzweig V (1994) Structural and functional properties of Trypanosoma trans-sialidase. Annu Rev Microbiol 48: 499–523.
331.
Schultze B, Krempl C, Ballesteros ML, Shaw L, Schauer R, Enjuanes L, Herrler G (1996) Transmissible gastroenteritis coronavirus, but not the related porcine respiratory coronavirus, has a sialic acid (N-glycolylneuraminic acid) binding activity. J Virol 70: 5634–5637.
332.
Schutzbach JS, Jensen JW, Lai CS, Monti JA (1987) Membrane structure and mannosyltransferase activities: The effect of dolichols on membranes. Chem Scripta 27: 109–118.
333.
Schutzbach JS, Forsee WT (1990) Calcium ion activation of rabbit liver α1,2-mannosidase. J Biol Chem 265: 2546–2549.
334.
Schutzbach JS, Zimmerman JW (1992) Yeast dolichyl-phospho-mannose synthase: Reconstitution of enzyme activity with phospholipids. Biochem Cell Biol 70: 460–465.
335.
Schutzbach JS (1997) The role of the lipid matrix in the biosynthesis of dolichyl-linked oligosaccharides. Glycoconj J 14: 175–182.
336.
Seko A, Ohkura T, Kitamura H, Yonezawa S, Sato E, Yamashita K (1996) Quantitative differences in GlcNAc:β1-3 and GlcNAcβ1-4 galactosyltransferase activities between human colonic adenocarcinomas and normal colonic mucosa. Cancer Res 56: 3468–3473.
337.
Serafini-Cessi F, Malagolini N, Dall’Olio F (1988) Characterization and partial purification of β-N-acetylgalactosaminyltransferase from urine of Sd(a+) individuals. Arch Biochem Biophys 266: 573–582.
338.
Serafini-Cessi F, Malagolini N, Guerrini S, Turrini I (1995) A soluble form of Sda-β1,4-N-acetylgalactosaminyltransferase is released by differentiated human colon carcinoma CaCo-2 cells. Glycoconj J 12: 773–779.
339.
Seto NOL, Palcic MM, Compston CA, Li H, Bundle DR, Narang SA (1997) Sequential interchange of four amino acids from blood group B to blood group A glycosyltransferase boosts catalytic activity and progressively modifies substrate recognition in human recombinant enzymes. J Biol Chem 272: 14133–14138.
340.
Shaper NL, Shaper JH, Bertness V, Chang H, Kirsch IR, Hollis GF (1986) The human galactosyltransferase gene is on chromosome 9 at band p13. Somat Cell Mol Genet 12: 633–636.
341.
Shaper NL, Harduin-Lepers A, Shaper JH (1994) Male germ cell expression of murine beta 4-galactosyltransferase – A 796-base pair genomic region, containing two cAMP-responsive element (CRE)-like elements, mediates male germ cell-specific expression in transgenic mice. J Biol Chem 269: 25165–25171. Sharma C, Radhakrishnamurthy B, Berenson G (1988) Activation of dolichol-phosphate mannosyltransferase by dibutyryl cyclic AMP in rat liver. Biochem Biophys Res Commun 155: 615–621.
342.
Sharma CB, Kaushal GP, Pan YT, Elbein AD (1990) Purification and characterization of dolichyl-P-mannose: Man5(GlcNAc)2-P-P-dolichol mannosyltransferase. Biochemistry 29: 8901–8907.
343.
Sharma A, Okabe J, Birch P, McClellan SB, Martin MJ, Platt JL, Logan JS (1996) Reduction in the level of Gal(alpha1,3)Gal in transgenic mice and pigs by the expression of an alpha(1,2) fucosyltransferase. Proc Natl Acad Sci USA 93: 7190–7195.
344.
Sheares BT, Lau JYT, Carlson DM (1982) Biosynthesis of galactosyl-β 1,3-N-acetylglucosamine. J Biol Chem 257: 599–602.
345.
Shi ZR, McIntyre J, Knowles BB, Solter D, Kim YS (1984) Expression of a carbohydrate differentiation antigen, stage-specific embryonic antigen 1, in human colonic adenocarcinoma. Cancer Res 44: 1142–1147.
346.
Shi WX, Chammas R, Varki A (1996) Linkage-specific action of endogenous sialic acid O-acetyltransferase in Chinese hamster ovary cells. J Biol Chem 271: 15130–15138.
347.
Shi WX, Chammas R, Varki A (1998) Induction of sialic acid 9-O-actylation by diverse gene products: Implications for the expression cloning of sialic acid O-acetyltransferases. Glycobiology 8: 199–205.
348.
Shigeta S, Winter H, Goldstein I (1994) α(2-3) and α(2-6) sialyltransferase activities present in three variants of Ehrlich tumor cells: Identification of the products derived from N-acetyllactosamine and β-D-Gal(1-3)-α-D- GalNAc (1-0)-Bn. Carbohydr Res 264: 111–121.
349.
Shilatifard A, Merkle RK, Helland DE, Welles JL, Hasseltine WA, Cummings RD (1993) Complex-type N-linked oligosaccharides of gp120 from human immunodeficiency virus type 1 contain sulfated N-acetylglucosamine. J Virol 67: 943–952.
350.
Shimodaira K, Nakayama J, Nakamura N, Hasebe O, Katsuyama T, Fukuda M (1997) Carcinoma-associated expression of core 2 β-1,6-N-acetylglucosaminyltransferase gene in human colorectal cancer: Role of O-glycans in tumor progression. Cancer Res 57: 5201–5206.
351.
Shimizu H, Tsuchie H, Yoshida K, Morikawa S, Tsuruoka T, Yamamoto H, Ushijima H, Kitamura T (1990) Inhibitory effect of novel 1-deoxynojirimycin derivatives on HIV-1 replication. AIDS 4: 975–979.
352.
Shinkel T, Chen C, Salvaris C, Henion T, Barlow H, Galili U, Pearse M, D’Apice A (1997) Changes in cell surface glycosylation in α1,3-galactosyltransferase knockout and α1,2-fucosyltransferase transgenic mice. Transplantation 64: 197–204.
353.
Shoreibah MG, Hindsgaul O, Pierce M (1992) Purification and characterization of rat kidney UDP-N-acetylglucosamine:α-6-D-Mannoside β-1,6-N-acetylglucosaminyltransferase. J Biol Chem 267: 2920–2927.
354.
Shumak K, Beldotti L, Rachkewich R (1979) Diagnosis of hematological disease using anti-i. Br J Haematol 41: 399–405.
355.
Silberstain S, Gilmore R (1996) Biochemistry, molecular biology and genetics of the oligosaccharyltransferase. FASEB J 10: 849–858.
356.
Simsek S, Heyboer H, de Bruijne-Admiraal LG, Goldschmeding R, Cuijpers HT, von dem Borne AE (1993) Glanzmann’s thrombasthenia caused by homozygosity for a splice defect that leads to deletion of the first coding exon of the glycoprotein IIIa mRNA. Blood 81: 2044–2049.
357.
Skacel P, Watkins W (1988) Significance of altered α-2-L-fucosyltransferase levels in serum of leukemic patients. Cancer Res 48: 3998–4001.
358.
Skacel P, Edwards A, Harrison C, Watkins W (1991) Enzymic control of the expression of the X determinant (CD15) in human myeloid cells during maturation: The regulatory role of 6′-sialyltransferase. Blood 78: 1452–1460.
359.
Skrincosky D, Kain R, El-Battari A, Exner M, Kerjaschki D, Fukuda M (1997) Altered Golgi localization of core 2 β-1,6-N-acetylglucosaminyltransferase leads to decreased synthesis of branched O-glycans. J Biol Chem 272: 22695–22702.
360.
Slomiany BL, Murty VLN, Piotrowski J, Liau YH, Slomiany A (1993) Glycosulfatase activity of Porphyromonas gingivalis, a bacterium associated with peridontal disease. Biochem Mol Biol Int 29: 973–980.
361.
Slomski CA, Durham JP, Watne AL (1988) Glycosyltransferase levels in familial polyposis coli. J Surg Res 40: 406–410.
362.
Smith PL, Gersten KM, Petryniak B, Kelly RJ, Rogers C, Natsuka Y, Alford JA III, Scheidegger EP, Natsuka S, Lowe JB (1996) Expression of the α(1,3)fucosyltransferase Fuc-TVII in lymphoid aggregate high endothelial venules correlates with expression of L-selectin ligands. J Biol Chem 271: 8250–8259.
363.
Snouwaert J, Brigman K, Latour A, Malouf N, Boucher R, Smithies O, Koller B (1992) An animal model for cystic fibrosis made by gene targeting. Science 257: 1083–1088.
364.
Springer GF (1995) T and Tn pancarcinoma markers: Autoantigenic adhesion molecules in pathogenesis, prebiopsy carcinoma-detection, and long-term breast carcinoma immunotherapy. Crit Rev Oncog 6: 57–85.
365.
Stanley P, Narasimhan S, Siminovitch L, Schachter H (1975) Chinese hamster ovary cells selected for resistance to the cytotoxicity of phytohemagglutinin are deficient in a UDP N-acetylglucosaminyl glycoprotein N-acetylglucosaminyltransferase activity. Proc Natl Acad Sci USA 72: 3323–3327.
366.
Stibler H, Westerberg B, Hanefeld F, Hagberg B (1993) Carbohydrate-deficient glycoprotein (CDG) syndrome – A new variant, type III. Neuropediatrics 24: 51–52.
367.
Stibler H, Stephani U, Kutsch U (1995) Carbohydrate-deficient glycoprotein syndrome – A fourth subtype. Neuropediatrics 26: 235–237.
368.
Stocks SC, Hopwood D, Sanders DSA, Kerr MA (1994) The expression of Lewisx on carcinoembryonic antigen (CEA)-related glycoproteins of normal and inflamed oesophageal squamous mucosa. Glycosyl Dis 1: 279–286.
369.
Strous GJ (1986) Golgi and secreted galactosyltransferase. Crit Rev Biochem 21: 119–151.
370.
Suda K, Sakamoto S, Hida K, Kano Y, Takaku F, Miura Y (1987) Electrofocussing pattern of fucosyltransferase activity in human leukemic cells. Cancer Res 47: 2782–2786.
371.
Sutherlin M, Nishimori I, Caffrey T, Bennett E, Hassan H, Mandel U, Mack D, Iwamura T, Clausen H, Hollingsworth M (1997) Expression of three UDP-N-acetyl-α-D-galactosamine: polypeptide GalNAc N-acetylgalactosaminyl transferase in adenocarcinoma cell lines. Cancer Res 57: 4744–4748.
372.
Svensson EC, Conley PB, Paulson JC (1992) Regulated expression of alpha2,6-sialyltransferase by the liver-encriched transcription factors HNF-1, DBP, and LAP. LAP. J Biol Chem 267: 3466–3472.
373.
Taguchi T, Kitajima K, Inoue S, Inoue Y, Yang J, Schachter H, Brockhausen I (1997) Activity of UDP-GlcNAc: GlcNAcβ1-6(GlcNAcβ1-2)Manα1-R (GlcNAc to Man) β1,4 N-acetylglucosaminyltransferase VI (GnT VI) from the ovaries of Oryzias latipes (Medaka fish). Biochem Biophys Res Commun 230: 533–536.
374.
Takahashi N, Lee KB, Nakagawa H, Tsukamoto Y, Kawamura Y, Li Y-T, Lee YC (1995) Enzymatic sialylation of N-linked oligosaccharides using an α-(2,3)-specific transsialidase from Trypanosoma cruzi:Structural identification using a three-dimensional elution mapping technique. Anal Biochem 230: 333–342.
375.
Takano R, Muchmore E, Dennis JW (1994) Sialylation and malignant potential in tumour cell glycosylation mutants. Glycobiology 4: 665–674.
376.
Taketa K, Sekiya C, Namiki M, Akamatsu K, Ohta Y, Endo Y, Kosaka K (1990) Lectin-reactive profiles of alpha-fetoprotein characterizing hepatocellular carcinoma and related conditions. Gastroenterology 99: 508–518.
377.
Tan J, D’Agostaro GAF, Bendiak B, Reck F, Sarkar M, Squire JA, Leong P, Schachter H (1995) The human UDP-N-acetylglucosamine: alpha-6-D-mannoside-beta-1,2-N-acetylglucosaminyltransferase II gene (MGAT2) – Cloning of genomic DNA, localization to chromosome 14q21, expression in insect cells and purification of the recombinant protein. Eur J Biochem 231: 317–328.
378.
Tan J, Dunn J, Jaeken J, Schachter H (1996) Mutations in the MGAT2 gene controlling complex N-glycan synthesis cause carbohydrate-deficient glycoprotein syndrome type II, an autosomal recessive disease with defective brain development. Am J Hum Genet 59: 810–817.
379.
Tanemura M, Miyagawa S, Ihara Y, Matsuda H, Shirakura R, Taniguchi N (1997) Significant downregulation of the major swine xenoantigen by N-acetylglucosaminyltransferase III gene transfection. Biochem Biophys Res Commun 235: 359–364.
380.
Taub R, Baker M, Madyastha K (1980) Masking of neutrophil surface lectin binding sites in chronic myelogenous leukemia (CML). Blood 55: 294–303.
381.
Taylor-Papdimitriou J, Stewart L, Burchell J, Beverley P (1993) The polymorphic epithelial mucin as a target for immunotherapy. Ann NY Acad Sci 690: 69–79.
382.
Tearle RG, Tange MJ, Zannettino ZL, Katerelos M, Shinkel TA, Van Denderen BJW, Lonie AJ, Lyons I, Nottle MB, Cox T, Becker C, Peura AM, Wigley PL, Crawford RJ, Robins AJ, Pearse MJ, d’Apice AJF (1996) The a-1,3-galactosyltransferase knockout mouse. Implications for xenotransplantation. Transplantation 61: 13–19.
383.
Thompson S, Dargan E, Turner GA (1992a) Increased fucosylation and other carbohydrate changes in haptoglobin in ovarian cancer. Cancer Lett 66: 43–48.
384.
Thompson S, Cantwell BMJ, Matta KL, Turner GA (1992b) Parallel changes in the blood levels of abnormally-fucosylated haptoglobin and alpha 1,3 fucosyltransferase in relationship to tumour burden: More evidence for a disturbance of fucose metabolism in cancer. Cancer Lett 65: 115–121.
385.
Thurnher M, Clausen H, Fierz W, Lanzavecchia A, Berger EG (1992) T-cell clones with normal or defective O-galactosylation from a patient with permanent mixed-field polyagglutinability. Eur J Immunol 22: 1835–1842.
386.
Thurnher M, Rusconi S, Berger EG (1993) Persistent repression of a functional allele can be responsible for galactosyltransferase deficiency in Tn Syndrome. J Clin Invest 91: 2103–2110.
387.
Tikkanen K, Haataja S, François-Gerard C, Finne J (1995) Purification of a galactosyl-α1-4-galactose-binding adhesin from the Gram-positive meningitis-associated bacterium Streptococcus suis. J Biol Chem 270: 28874–28878.
388.
Toki D, Sarkar M, Yip B, Reck F, Joziasse D, Fukuda M, Schachter H, Brockhausen I (1997) Role of N-linked glycosylation of recombinant human core 2 β6-N-acetylglucosaminyltransferase expressed in Sf9 insect cells. Biochem J 325: 63–69.
389.
Tomiyama Y, Kashiwagi H, Kosugi S, Shiraga M, Kanayama Y, Kurata Y, Matsuzawa Y (1995) Abnormal processing of the glycoprotein IIb transcript, due to a nonsense mutation in exon 17 associated with Glanzmann’s thrombasthenia. Thromb Haemost 74: 811.
390.
Torrado J, Ruiz B, Garay J, Asenjo JLG, Tovar JA, Cosme A, Correa P (1997) Blood-group phenotypes, sulfomucins, and Helicobacter pylori in Barrett’s esophagus. Am J Surg Pathol 21: 1023–1029.
391.
Troy F (1992) Polysialylation: From bacteria to brains. Glycobiology 2: 5–23.
392.
Tsuboi S, Isogai Y, Hada N, King JK, Hindsgaul O, Fukuda M (1996) 6’-Sulfo sialyl Lex but not 6-sulfo sialyl Lex expressed on the cell surface supports L-selectin-mediated adhesion. J Biol Chem 271: 27213–27216.
393.
Tsuboi S, Fukuda M (1997) Branched O-linked oligosaccharides ectopically expressed in transgenic mice reduce primary T-cell immune responses. EMBO J 16: 6364–6373.
394.
Tsuchiya N, Endo T, Matsuta K, Yoshinoya S, Aikawa T, Kosuge E, Takeuchi F, Miyamoto T, Kobata A (1989) Effects of galactose depletion from oligosaccharide chains on immunological activities of human IgG. J Rheumatol 16: 285–290.
395.
Turner GA (1995) Haptoglobin. A potential reporter molecule for glycosylation changes in disease. Adv Exp Med Biol 376: 231–238.
396.
Uozumi N, Yanagidani S, Miyoshi E, Ihara Y, Sakuma T, Gao CX, Teshima T, Fuji S, Shiba T, Taniguchi N (1996) Purification and cDNA cloning of porcine brain GDP-L-Fuc: N-acetyl-β-D-glucosaminide α1-6fucosyltransferase. J Biol Chem 271: 27810–27817.
397.
van Dijk W, Havenaar EC, Brinkman-van der Linden ECM (1995) α1-Acid glycoprotein (orosomucoid): Pathophysiological changes in glycosylation in relation to its function. Glyconconj J 12: 227–233.
398.
van Halbeek H, Dorland L, Vliegenthart J, Hull W, Lamblin G, Lhermitte M, Boersma A, Roussel P (1982) Primary-structure determination of fourteen neutral oligosaccharides derived from bronchial mucus glycoproteins of patients suffering from cystic fibrosis, employing 500 MHz H NMR spectroscopy. Eur J Biochem 127: 7–20.
399.
van Schaftingen E, Jaeken J (1995) Phosphomannomutase deficiency is a cause of carbohydrate-deficient glycoprotein syndrome type I. FEBS Lett 377: 318–320.
400.
Varki A (1992) Diversity in the sialic acids. Glycobiology 2: 25–40.
401.
Varki A (1993) Biological roles of oligosaccharides: All of the theories are correct. Glycobiology 3: 97–130.
402.
Vavasseur F, Dole K, Yang J, Matta K, Myerscough N, Corfield A, Paraskeva C, Brockhausen I (1994) O-glycan biosynthesis in human colorectal adenoma cells during progression to cancer. Eur J Biochem 222: 415–424.
403.
Vavasseur F, Yang J, Dole K, Paulsen H, Brockhausen I (1995) Synthesis of core 3: Characterization of UDP-GlcNAc: GalNAc β3-N-acetylglucosaminyl-transferase activity from colonic tissues. Loss of the activity in human cancer cell lines. Glycobiology 5: 351–357.
404.
Veerman ECI, Bank CMC, Namavar F, Appelmelk BJ, Bolscher JGM, Nieuw Amerongen AV (1997) Sulfated glycans on oral mucin as receptors for Helicobacter pylori. Glycobiology 7: 737–743.
405.
Vermelho AB, Meirelles MN (1994) Sialoglycoconjugates in Trypanosoma cruzi-host cell interaction: Possible biological models – A review. Mem Inst Oswaldo Cruz 89: 69–79.
406.
von Andrian UH, Berger EM, Ramezani L, Chambers JD, Ochs HD, Harlan JM, Paulson JC, Etzioni A, Arfors KE (1993) In vivo behavior of neutrophils from two patients with distinct inherited leukocyte adhesion deficiency syndrome. J Clin Invest 91: 2893–2897.
407.
Walsh MD, McGuckin MA, Devine PL, Hohn BG, Wright RG (1993) Expression of MUC2 epithelial mucin in breast carcinoma. J Clin Pathol 46: 922–925.
408.
Wang XC, Smith TJ, Lau JTY (1990a) Transcriptional regulation of liver β-galactoside α2,6-sialyltransferase by glucocorticoids. J Biol Chem 265: 17849–17853.
409.
Wang Y-M, Hare TR, Won B, Stowell CP, Scanlin TF, Glick MC, Hård K, van Kuik JA, Vliegenthart JFG (1990b) Additional fucosyl residues on membrane glycoproteins but not a secreted glycoprotein from cystic fibrosis fibroblasts. Clin Chim Acta 188: 193–210.
410.
Wang XC, Vertino A, Eddy RL, Byers MG, Jani-Sait SN, Shows TB, Lau JTY (1993) Chromosome mapping and organization of the human beta-galactoside alpha2,6-sialyltransferase gene. Differential and cell-type specific usage of upstream exon sequences in B-lymphoblastoid cells. J Biol Chem 268: 4355–4361.
411.
Wang Y, Lee GF, Kelley FR, Spellman MW (1996) Identification of a GDP-L-fucose: polypeptide fucosyltransferase and enzymatic addition of O-linked fucose to EGF domains. Glycobiology 6: 837–842.
412.
Wang Y, Wu K, Harris R, Spellman M (1997) Purification and molecular cloning of a GDP-fucose: polypeptide fucosyltransferase specific for EGF domain glycosylation. Glycobiology 7: 1033.
413.
Ward HD (1997) Glycobiology of parasites: Role of carbohydrate-binding proteins and their ligands in the host-parasite interaction; in Gabius HJ, Gabius S (eds): Glycosciences Status and Perspectives. Weinheim, Chapman & Hall, pp 399–413.
414.
Weinstein J, Sunderam S, Wang S, Delgado D, Basu R, Stanley P (1996) A point mutation causes mistargeting of Golgi GlcNAc-TV in the Lec4A Chinese hamster ovary glycosylation mutant. J Biol Chem 271: 27462–27469.
415.
Wesley A, Forstner J, Qureshi R, Mantle M, Forstner G (1983) Human intestinal mucin in cystic fibrosis. Pediatr Res 17: 65–69.
416.
White T, Bennett EP, Takio K, Sorensen T, Bonding N, Clausen H (1995) Purification and cDNA cloning of a human UDP-N-acetyl-alpha-D-galactosamine: polypeptide N-acetylgalactosaminyltransferase. J Biol Chem 270: 24156–24165.
417.
Whitehouse C, Burchell J, Gschmeissner S, Brockhausen I, Lloyd K, Taylor-Papadimitriou J (1997) A transfected sialyltransferase that is elevated in breast cancer and localizes to the medial/trans-Golgi apparatus inhibits the development of core-2-based O-glycans. J Cell Biol 137: 1229–1241.
418.
Williams D, Schachter H (1980) Mucin synthesis. I. Detection in canine submaxillary glands of an N-acetylglucosaminyltransferase which acts on mucin substrates. J Biol Chem 255: 11247–11252.
419.
Winchester B, Clayton P, Mian N, di-Tomaso E, Dell A, Reason A, Keir G (1995) The carbohydrate-deficient glycoprotein syndrome: An experiment of nature in glycosylation. Biochem Soc Proc 23: 185–188.
420.
Yamamoto FI, Clausen H, White T, Marken J, Hakomori S-I (1990) Molecular genetic basis of the histo-blood Group ABO system. Nature 345: 229–233.
421.
Yamamoto FI, Hakomori SI (1990) Sugar-nucleotide donor specificity of histo-blood group A and B transferases is based on amino acid substitutions. J Biol Chem 265: 19257–19262.
422.
Yamashita K, Tachibana Y, Ohkura T, Kobata A (1985) Enzymatic basis for the structural changes of asparagine-linked sugar chains of membrane glycoproteins of baby hamster kidney cells induced by polyoma transformation. J Biol Chem 260: 3963–3969.
423.
Yamashita K, Totani K, Kuroki M, Matsuoka Y, Ueda I, Kobata A (1987) Structural studies of the carbohydrate moieties of carcino-embryonic antigens. Cancer Res 47: 3451–3459.
424.
Yamashita K, Koide N, Endo T, Iwaki Y, Kobata A (1989) Altered glycosylation of serum transferrin of patients with hepatocellular carcinoma. J Biol Chem 264: 2415–2423.
425.
Yamashita K, Taketa K, Nishi S, Fukushima K, Ohkura T (1993) Sugar chains of human cord serum α-fetoprotein: Characteristics of N-linked sugar chains of glycoproteins produced in human liver and hepatocellular carcinomas. Cancer Res 53: 2970–2975.
426.
Yamori T, Kimura H, Stewart K, Ota D, Cleary K, Irimura T (1987) Differential production of high molecular weight sulfated glycoproteins in normal colonic mucosa, primary colon carcinoma, and metastases. Cancer Res 47: 2741–2747.
427.
Yanagidani S, Uozumi N, Ihara Y, Miyoshi E, Yamaguchi N, Taniguchi N (1997) Purification and cDNA cloning of GDP-L-Fuc: N-acetyl-β-D-glucosaminide: α1-6 fucosyltransferase (α1-6 FucT) from human gastric cancer MKN45 cells. J Biochem 121: 626–632.
428.
Yang J, Byrd J, Siddiki B, Chung Y, Okuno M, Sowa M, Kim Y, Matta K, Brockhausen I (1994) Alterations of O-glycan biosynthesis in human colon cancer tissue. Glycobiology 4: 873–884.
429.
Yao M, Zhou DP, Jiang SM, Wang QH, Zhou ZY, Gu JX (1998) Elevated activity of N-acetylglucosaminyltransferase V in human hepatocellular carcinoma. J Cancer Res Clin Oncol 124: 27–30.
430.
Yazawa S, Abbas SA, Madiyalakan R, Barlow JJ, Matta KL (1986) N-Acetyl-β-D-glucosaminyltransferases related to the synthesis of mucin-type glycoproteins in human ovarian tissue. Carbohydr Res 149: 241–252.
431.
Yet MG, Shao MC, Wold F (1988) Effects of the protein matrix on glycan processing in glycoproteins. FASEB J 2: 22–31.
432.
Yip B, Chen S, Mulder H, Höppener JWM, Schachter H (1997) Organization of the human beta-1,2-N-acetylglucosaminyltransferase I gene (MGAT1) which controls complex and hybrid N-glycan synthesis. Biochem J 321: 465–474.
433.
Yogeeswaran G, Salk PL (1981) Metastatic potential is positively correlated with cell surface sialylation of cultured murine tumor cell lines. Science 212: 1514–1516.
434.
Yoon W, Park H, Lim K, Hwang B (1996) Effect of O-glycosylated mucin on invasion and metastasis of HM7 human colon cancer cells. Biochem Biophys Res Commun 222: 694–699.
435.
Yoshida N, Dorta ML, Ferreira AT, Oshiro MEM, Mortara RA, Acosto-Serrano A, Favoreto S (1997) Removal of sialic acid from mucin-like surface molecules of Trypanosoma cruzi metacyclic trypomastigotes enhances parasite-host cell interaction. Mol Biochem Parasitol 84: 57–67.
436.
Yoshimura M, Ihara Y, Taniguchi N (1995a) Changes of β-1,4-N-acetyl-glucosaminyltransferase III (GnT-III) in patients with leukaemia. Glycoconj J 12: 234–240.
437.
Yoshimura M, Nishikawa A, Ihara Y, Taniguchi S, Taniguchi N (1995b) Suppression of lung metastases of B16 mouse melanoma by N-acetylglucosaminyltransferase III gene transfection. Proc Natl Acad Sci USA 92: 8754–8758.
438.
Yoshimura M, Nishikawa A, Ihara Y, Nishiura T, Nakao H, Kanayama Y, Matsuzawa Y, Taniguchi N (1995c) High expression of UDP-N-acetylglucosamine: β-D-mannoside β-1,4-N-acetylglucosaminyltransferase III (GnT III) in chronic myelogenous leukemia in blastic crisis. Int J Cancer 60: 443–449.
439.
Yoshimura M, Ihara Y, Ohnishi A, Ijuhin N, Nishiura T, Kanakura Y, Matsuzawa Y, Tanaguchi N (1996) Bisecting N-acetylglucosamine on K562 cells suppresses natural killer cytotoxicity and promotes spleen colonization. Cancer Res 56: 412–418.
440.
Yousefi S, Higgins E, Daoling Z, Pollex-Krüger A, Hindsgaul O, Dennis J (1991) Increased UDP-GlcNAc: Galβ1-3GalNAc-R(GlcNAc to GalNAc) β1-6 N-acetylglucosaminyltransferase activity in metastatic murine tumor cell lines. Control of polylactosaminoglycan synthesis. J Biol Chem 266: 1772–1782.
441.
Yuan M, Itzkowitz SH, Ferrell LD, Fukushi Y, Palekar A, Hakomori SI, Kim YS (1987) Expression of Lewisx and sialylated Lewisx antigens in human colorectal polyps. J Natl Cancer Inst 78: 479–488.
442.
Zamze S (1991) Glycosylation in parasitic protozoa of the Trypanosomatidae family. Glycoconj J 8: 443–447.
443.
Zhang N, Peng KC, Chen L, Puett D, Pierce M (1997) Circular dichroic spectroscopy of N-acetylglucosaminyltransferase V and its substrate interactions. J Biol Chem 272: 4225–4229.
444.
Zhu BCR, Laine RA (1985) Polyactosamine glycosylation on human fetal placental fibronectin weakens the binding affinity of fibronectin to gelatin. J Biol Chem 260: 4041–4045.
445.
Zhuang D, Yousefi S, Dennis JW (1991) Tn antigen and UDP-Gal:GalNAcα-R β1-3galactosyltransferase expression in human breast carcinoma. Cancer Biochem Biophys 12: 185–198.
1998
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.